<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-09357R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0005808</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Neuroscience</subject><subject>Neuroscience/Animal Cognition</subject><subject>Neuroscience/Behavioral Neuroscience</subject><subject>Neuroscience/Neurobiology of Disease and Regeneration</subject><subject>Neuroscience/Neuronal Signaling Mechanisms</subject><subject>Neurological Disorders/Epilepsy</subject></subj-group></article-categories><title-group><article-title>Regulation of Hippocampal and Behavioral Excitability by Cyclin-Dependent Kinase 5</article-title><alt-title alt-title-type="running-head">Cdk5 KO Increases Excitability</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hawasli</surname><given-names>Ammar H.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Koovakkattu</surname><given-names>Della</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hayashi</surname><given-names>Kanehiro</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Anderson</surname><given-names>Anne E.</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Powell</surname><given-names>Craig M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sinton</surname><given-names>Christopher M.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bibb</surname><given-names>James A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cooper</surname><given-names>Donald C.</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Departments of Pediatrics, Neurology and Neuroscience, Baylor College of Medicine, Houston, Texas, United States of America</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Department of Psychology and Neuroscience, Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Brezina</surname><given-names>Vladimir</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Mount Sinai School of Medicine, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>james.bibb@utsouthwestern.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: AHH JAB DCC. Performed the experiments: AHH. Analyzed the data: AHH JAB DCC. Contributed reagents/materials/analysis tools: AHH CMS JAB DCC. Wrote the paper: AHH JAB DCC. Designed and supervised the experiments conducted in his/her laboratory: JAB AEA CMP CMS. Performed experiments: DK KH. Designed and supervised the experiments conducted in his/her laboratory: JAB AEA CMP CMS DCC. Performed experiments: DK KH.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>4</day><month>6</month><year>2009</year></pub-date><volume>4</volume><issue>6</issue><elocation-id>e5808</elocation-id><history><date date-type="received"><day>9</day><month>3</month><year>2009</year></date><date date-type="accepted"><day>7</day><month>5</month><year>2009</year></date></history><copyright-statement>Hawasli et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2009</copyright-year><abstract><p>Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/threonine kinase that has been implicated in learning, synaptic plasticity, neurotransmission, and numerous neurological disorders. We previously showed that conditional loss of Cdk5 in adult mice enhanced hippocampal learning and plasticity via modulation of calpain-mediated <italic>N</italic>-methyl-D-aspartic acid receptor (NMDAR) degradation. In the present study, we characterize the enhanced synaptic plasticity and examine the effects of long-term Cdk5 loss on hippocampal excitability in adult mice. Field excitatory post-synaptic potentials (fEPSPs) from the Schaffer collateral CA1 subregion of the hippocampus (SC/CA1) reveal that loss of Cdk5 altered theta burst topography and enhanced post-tetanic potentiation. Since Cdk5 governs NMDAR NR2B subunit levels, we investigated the effects of long-term Cdk5 knockout on hippocampal neuronal excitability by measuring NMDAR-mediated fEPSP magnitudes and population-spike thresholds. Long-term loss of Cdk5 led to increased Mg<sup>2&#x0002b;</sup>-sensitive potentials and a lower threshold for epileptiform activity and seizures. Biochemical analyses were performed to better understand the role of Cdk5 in seizures. Induced-seizures in wild-type animals led to elevated amounts of p25, the Cdk5-activating cofactor. Long-term, but not acute, loss of Cdk5 led to decreased p25 levels, suggesting that Cdk5/p25 may be activated as a homeostatic mechanism to attenuate epileptiform activity. These findings indicate that Cdk5 regulates synaptic plasticity, controls neuronal and behavioral stimulus-induced excitability and may be a novel pharmacological target for cognitive and anticonvulsant therapies.</p></abstract><counts><page-count count="13"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Cyclin-dependent kinase 5 (Cdk5), a proline-directed serine/threonine protein kinase, and its neuronal-specific activating cofactors have been implicated in numerous physiological and pathological processes in the mammalian nervous system <xref ref-type="bibr" rid="pone.0005808-Benavides1">&#x0005b;1&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005808-Wei1">&#x0005b;14&#x0005d;</xref>. Cdk5 has been implicated in hippocampal learning and synaptic plasticity <xref ref-type="bibr" rid="pone.0005808-Fischer1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Ohshima1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Hawasli2">&#x0005b;15&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005808-Fischer2">&#x0005b;17&#x0005d;</xref> and the pathogenesis of neurodegenerative disorders, such as Alzheimer's disease and neuropsychiatric illnesses, such as addiction <xref ref-type="bibr" rid="pone.0005808-Bibb1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Hawasli2">&#x0005b;15&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Bibb3">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Cruz1">&#x0005b;19&#x0005d;</xref>.</p><p>We previously reported that Cdk5 controls hippocampus-dependent learning and synaptic plasticity <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>. Conditional loss of Cdk5 improved performance in several hippocampal learning tasks and reduced the threshold for LTP induction. The enhancement in synaptic plasticity was due to increased NMDAR-mediated currents secondary to elevated surface expression of NR2B. Cdk5 was shown to facilitate the calpain-mediated degradation of NR2B upon activation of NMDARs. The regulation of NMDAR degradation appears to play a critical role in synaptic plasticity <xref ref-type="bibr" rid="pone.0005808-Simpkins1">&#x0005b;20&#x0005d;</xref>.</p><p>Our initial study revealed a number of positive effects that resulted from conditional loss of Cdk5 in the brains of adult mice <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Hawasli2">&#x0005b;15&#x0005d;</xref>. Inducible loss of Cdk5 in adult mice improved learning and increased NMDAR-mediated synaptic plasticity (2&#x02013;4 weeks after knockout) <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Hawasli2">&#x0005b;15&#x0005d;</xref>. Here, we report the effects of adult, conditional Cdk5 loss on the induction of synaptic plasticity and hippocampal and stimulation-induced behavioral excitability. Since the loss of Cdk5 enhanced plasticity via increased NMDAR-mediated currents, we examined NMDAR-mediated field excitatory postsynaptic potential (fEPSP) magnitudes and population-spike thresholds in knockout (KO) and control (WT) mice. Although enhanced hippocampal plasticity is associated with increased learning we hypothesized that synaptic plasticity associated with loss of Cdk5 would also lead to increased hippocampal epileptiform activity and seizure susceptibility.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Conditional knockout of Cdk5</title><p>To circumvent the neonatal lethality of the constitutive Cdk5 KO mice and non-specificity of pharmacological inhibitors <xref ref-type="bibr" rid="pone.0005808-Ohshima2">&#x0005b;11&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Yan1">&#x0005b;21&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005808-Powell1">&#x0005b;23&#x0005d;</xref>, conditional KO of Cdk5 was achieved by deriving mice in which loxP elements flanked critical exons in both Cdk5 alleles. Recombination was mediated with a transgenic estrogen receptor-Cre recombinase fusion, under control of the prion promoter <xref ref-type="bibr" rid="pone.0005808-Weber1">&#x0005b;24&#x0005d;</xref> in response to a 15-day regimen of hydroxytamoxifen as previously described <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>. Hydroxytamoxifen-dosed wild-type littermate mice served as controls (WT).</p></sec><sec id="s2b"><title>Altered theta burst synaptic response accompanies enhanced LTP after conditional knockout of Cdk5</title><p>LTP was induced in hippocampi from Cdk5 WT and KO animals within the SC/CA1 pathway on a 64-channel multielectrode array (<xref ref-type="fig" rid="pone-0005808-g001"><bold>Figure 1A</bold></xref>). As expected, Cdk5 KO mice displayed a reduced threshold for LTP induction (<xref ref-type="fig" rid="pone-0005808-g001"><bold>Figure 1B</bold></xref>) <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>. To determine if this enhancement was due to increased responsiveness during the theta burst stimulation (TBS) used to induce LTP we examined the fEPSPs during TBS. In WT slices, theta bursts briefly led to facilitation followed by moderate depression. In contrast, in KO slices, a TBS produced an immediate depression and subsequent larger magnitude depression compared to controls (<xref ref-type="fig" rid="pone-0005808-g001"><bold>Figure 1C</bold></xref>). The 10 ms inter-stimulus interval produced a 8.1&#x000b1;6.3&#x00025; facilitation in WT slices, but in KO slices we observed a 12.9&#x000b1;4.7&#x00025; depression (<xref ref-type="fig" rid="pone-0005808-g001"><bold>Figure 1C</bold></xref>; Burst 1, EPSP 2). Interestingly, this significant and notable discrepancy between WT and KO mice was specific for the shortest intervals of 10 ms (100 Hz). Paired-pulse potentiation at inter-stimulus intervals (ISI) between 25 and 800 ms (40&#x02013;1.25 Hz) were not significantly different <xref ref-type="bibr" rid="pone.0005808-Meyer1">&#x0005b;9&#x0005d;</xref>. Repolarization after a theta burst stimulus is, in part, dependent on Ca<sup>2&#x0002b;</sup>-activated K<sup>&#x0002b;</sup>-channels <xref ref-type="bibr" rid="pone.0005808-Kramar1">&#x0005b;25&#x0005d;</xref>. To evaluate for possible aberrations in Ca<sup>2&#x0002b;</sup>-activated K<sup>&#x0002b;</sup>-channels, burst duration and repolarization were examined. Analysis revealed no differences between KO and WT in both burst duration and rebound during theta burst stimuli.</p><fig id="pone-0005808-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005808.g001</object-id><label>Figure 1</label><caption><title>Altered theta burst topography in SC/CA1 pathway accompanies enhanced LTP in Cdk5 KO mice.</title><p><italic>A</italic>, An acute hippocampal slice resting on MED-64 multi-electrode array. fEPSPs were recorded (blue) after stimulation of the SC/CA1 pathway (red). <italic>B</italic>, LTP after a ten-burst theta stimulus in representative WT and KO slices plotted as percent amplitude of baseline (&#x02212;10 to 0 min). <italic>C</italic>, Effects of Cdk5 KO on theta-burst responses. Representative theta burst traces were extracted from LTP experiment illustrated in <italic>B</italic>, Quantitation plotted as percentage change in amplitude (relative to the 1st fEPSP) of the 2<sup>nd</sup>, 3<sup>rd</sup>, and 4<sup>th</sup> field EPSP within a single stimulus train of 4 pulses at 100 Hz in control and KO slices. The measures are shown for bursts 1&#x02013;4 of a train. Similar results were obtained with slope calculations, n&#x0200a;&#x0003d;&#x0200a;5&#x02013;8. &#x0002a;P&#x0003c;0.05 vs. WT; <italic>post hoc t</italic>-test. Data represent mean&#x000b1;s.e.m.</p></caption><graphic xlink:href="pone.0005808.g001"/></fig></sec><sec id="s2c"><title>Responses to CA1 hippocampal tetanic stimuli in WT and Cdk5 KO mice</title><p>To further evaluate synaptic plasticity in WT versus Cdk5 KO mice, responses to high and low frequency tetani were measured. The fEPSP amplitudes were measured during a 100-Hz high frequency tetanus in the presence of NMDAR antagonism. As with the TBS in <xref ref-type="fig" rid="pone-0005808-g001"><bold>Figure 1</bold></xref>, this experiment revealed a paired-pulse disparity between KO and WT (<xref ref-type="fig" rid="pone-0005808-g002"><bold>Figure 2A</bold></xref>). Because this experiment was performed in the presence of a NMDAR-antagonist, the enhanced depression was not due to NMDA activation. After the 2<sup>nd</sup> pulse, Cdk5 KO and WT mice displayed similar responses to 100-Hz tetani (<xref ref-type="fig" rid="pone-0005808-g002"><bold>Figure 2A</bold></xref>). The fEPSPs during low frequency tetani are often measured to assess the status of the presynaptic reserve vesicle pool. A 14 Hz train in the presence of a NMDAR antagonist elicited equivalent fEPSP facilitation followed by vesicle depletion and fEPSP depression in both groups (<xref ref-type="fig" rid="pone-0005808-g002"><bold>Figure 2B</bold></xref>). In the presence of NMDA antagonism these data show no detectable aberration in the presynaptic reserve vesicle pool due to Cdk5 loss.</p><fig id="pone-0005808-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005808.g002</object-id><label>Figure 2</label><caption><title>Tetanic stimulation and post-tetanic potentiation after conditional loss of Cdk5.</title><p><italic>A</italic>, fEPSPs during high frequency tetanus. fEPSPs amplitudes during 100 Hz tetani are plotted relative to the 1<sup>st</sup> response in the presence of 75 &#x000b5;M AP5. Asterisk indicates that the 2<sup>nd</sup> fEPSP during the train was significantly different between WT and KO (P&#x0003c;0.05, student's <italic>t</italic>-test). <italic>B</italic>, Effects of Cdk5 KO on fEPSPs during low frequency tetanus. fEPSPs amplitudes during 14 Hz tetani are plotted relative to the 1<sup>st</sup> response in the presence of 75 &#x000b5;M AP5. <italic>C</italic>, Post-tetanic potentiation after a 100 Hz stimulus. Representative traces and fEPSP amplitudes were measured and plotted relative to baseline (75 &#x000b5;M AP5, n&#x0200a;&#x0003d;&#x0200a;5&#x02013;8; P&#x0003c;0.05, student's <italic>t</italic>-test). Data represent mean&#x000b1;s.e.m.</p></caption><graphic xlink:href="pone.0005808.g002"/></fig></sec><sec id="s2d"><title>Conditional loss of Cdk5 leads to an enhancement in CA1 hippocampal post-tetanic potentiation</title><p>After a high frequency tetanus, neurons exhibit a form of short-term plasticity called post-tetanic potentiation (PTP). Although much of this phenomenon remains uncharacterized, PTP is likely due to a tetanus-induced elevation in presynaptic Ca<sup>2&#x0002b;</sup> which leads to a short-lived increase in vesicle release <xref ref-type="bibr" rid="pone.0005808-Kamiya1">&#x0005b;26&#x0005d;</xref>. Changes in PTP could result from alterations in presynaptic Ca<sup>2&#x0002b;</sup> channel properties or the size of the readily releasable pool of vesicles. Conditional loss of Cdk5 led to an enhancement in PTP following a either a 100 Hz tetanus (<xref ref-type="fig" rid="pone-0005808-g002"><bold>Figure 2C</bold></xref>) or TBS <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>. In the presence of a NMDAR antagonist, a 100 Hz tetanus produced 120.7&#x000b1;4.3&#x00025; and 142.4&#x000b1;9.7&#x00025; PTP in WT and KO slices, respectively. These findings indicate that loss of Cdk5 enhances NMDA-independent short-term plasticity.</p></sec><sec id="s2e"><title>Conditional loss of Cdk5 leads to elevated Mg<sup>2&#x0002b;</sup>-sensitive potentials</title><p>In addition to their role in LTP induction, NMDARs play key roles in many intracellular signaling cascades, neuronal excitability as well as seizure generation <xref ref-type="bibr" rid="pone.0005808-McNamara1">&#x0005b;27&#x0005d;</xref>. Consequently, <italic>in vitro</italic> slice physiology epileptiform activity is often measured in Mg<sup>2&#x0002b;</sup>-free conditions <xref ref-type="bibr" rid="pone.0005808-Ohmori1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Pitkanen1">&#x0005b;29&#x0005d;</xref>. Since loss of Cdk5 led to a NMDAR-mediated enhancement in synaptic plasticity, we analyzed Mg<sup>2&#x0002b;</sup>-sensitive potentials in Cdk5 KO mice, thus allowing measurement of fEPSPs containing a predominant NMDA component. Mg<sup>2&#x0002b;</sup>-sensitive evoked fEPSP measurements were taken within the SC/CA1 hippocampal pathway. The removal of NMDA receptor Mg<sup>2&#x0002b;</sup>-blockade produced a 1.71-fold larger fEPSP amplitude change in KO than WT (148.9&#x000b1;7.6 vs. 128.6&#x000b1;4.7&#x00025; of baseline, respectively; <xref ref-type="fig" rid="pone-0005808-g003"><bold>Figure 3A</bold></xref><bold>, left</bold>). There was also greater overall charge transfer in Cdk5 KO mice versus controls as measured by fEPSP areas (162.3&#x000b1;4.4 vs. 145.2&#x000b1;5.7&#x00025; of baseline, respectively; <xref ref-type="fig" rid="pone-0005808-g003"><bold>Figure 3A</bold></xref><bold>, right</bold>). These findings indicate that loss of Cdk5 led to increased Mg<sup>2&#x0002b;</sup>-sensitive post-synaptic potentials suggesting increased NMDAR function.</p><fig id="pone-0005808-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005808.g003</object-id><label>Figure 3</label><caption><title>Increased Mg<sup>2&#x0002b;</sup>-sensitive post-synaptic potential and reduced threshold for epileptiform activity after conditional loss of Cdk5.</title><p><italic>A</italic>, Representative traces and quantitation of fEPSP amplitude (n&#x0200a;&#x0003d;&#x0200a;12) and area (n&#x0200a;&#x0003d;&#x0200a;6) in the <italic>stratum radiatum</italic> relative to baseline following Mg<sup>2&#x0002b;</sup> wash-out. <italic>B</italic>, Representative traces and quantitation showing reduced threshold for population spikes in the <italic>stratum pyramidale</italic> of KO slices after stimulation in the hippocampal SC/CA1 pathway in Mg<sup>2&#x0002b;</sup>-free conditions. Quantitation shows &#x00025; of slices displaying population spikes at indicated stimulation intensities (&#x00025; of maximum). Recordings were performed 4&#x02013;6 weeks post-KO. n&#x0200a;&#x0003d;&#x0200a;16&#x02013;18; <italic>ANOVA</italic> revealed a main effect of genotype (F<sub>1,217</sub>&#x0200a;&#x0003d;&#x0200a;36.16, p&#x0003c;0.0001), stimulation (F<sub>6,217</sub>&#x0200a;&#x0003d;&#x0200a;115.41, p&#x0003c;0.0001) and interaction between genotype and stimulation (F<sub>6,217</sub>&#x0200a;&#x0003d;&#x0200a;11.76, p&#x0003c;0.0001). &#x0002a;&#x0002a;P&#x0003c;0.05, &#x0002a;P&#x0003c;0.01, <sup>&#x02020;</sup>P&#x0200a;&#x0003d;&#x0200a;0.067 vs. WT, <italic>post hoc t</italic>-test. Data represent mean&#x000b1;s.e.m.</p></caption><graphic xlink:href="pone.0005808.g003"/></fig></sec><sec id="s2f"><title>Chronic loss of Cdk5 reduced threshold for epileptiform population-spike activity</title><p>Hippocampal NMDAR activation is an important step in many <italic>in vitro</italic> and <italic>vivo</italic> seizure models <xref ref-type="bibr" rid="pone.0005808-McNamara1">&#x0005b;27&#x0005d;</xref>. Abnormal neuronal excitability may produce epileptiform-like activity in acute brain slices. Hyperexcitability can be characterized by an increased propensity for populations of cells to fire in synchrony generating, so called, population spikes. We examined whether conditional loss of Cdk5 increased susceptibility to <italic>in vitro</italic> epileptiform activity in the SC/CA1 pathway after unmasking NMDARs. Synaptically-evoked fEPSPs in the <italic>stratum pyramidale</italic> were measured in Mg<sup>2&#x0002b;</sup>-free conditions. Stimulation of the SC/CA1 pathway at 20&#x00025;-maximal stimulation intensity produced population spikes in 3.7&#x000b1;2.5&#x00025; of WT and 10.4&#x000b1;5.0&#x00025; of KO slices. A stronger 50&#x00025;-maximal stimulation intensity produced population spikes in 89.6&#x000b1;4.0&#x00025; of KO slices but only 16.74&#x000b1;7.7&#x00025; of WT slices (<xref ref-type="fig" rid="pone-0005808-g003"><bold>Figure 3B</bold></xref>). Stronger stimulation intensities elicited population spikes in greater number and larger magnitude in both KO and WT slices. These results suggest show that loss of Cdk5 reduces the threshold to induce evoked epileptiform activity in hippocampal slices.</p><p>Aberrations in Na<sup>&#x0002b;</sup> channel properties can affect neuronal excitability <xref ref-type="bibr" rid="pone.0005808-Baulac1">&#x0005b;30&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005808-Wallace1">&#x0005b;33&#x0005d;</xref> and Na<sup>&#x0002b;</sup> channel antagonists serve as a therapeutic anticonvulsants. Basal population-spike thresholds are dependent on Na<sup>&#x0002b;</sup> channel activation. Therefore, we surveyed the basal <italic>in vitro</italic> population-spike threshold and the effects of partial Na<sup>&#x0002b;</sup> channel blockade on fEPSPs. To analyze population spike threshold, input/output measurements were collected in the <italic>strata radiatum</italic> and <italic>pyramidale</italic>. The stimulation thresholds to induce population spikes in both layers were equivalent between groups. Furthermore, partial blockade (&#x0003e;50&#x00025;) of Na<sup>&#x0002b;</sup> channels with 50 nM TTX produced no changes from baseline in fiber volley or fEPSP amplitudes in KO and WT groups (<xref ref-type="fig" rid="pone-0005808-g004"><bold>Figure 4A</bold></xref>). Loss of Cdk5 lowered the threshold for population spikes and this could not be rescued by substantial reduction (&#x0003e;50&#x00025;) in Na<sup>&#x0002b;</sup> channel availability <xref ref-type="bibr" rid="pone.0005808-Madeja1">&#x0005b;34&#x0005d;</xref>.</p><fig id="pone-0005808-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005808.g004</object-id><label>Figure 4</label><caption><title>GABA<sub>A</sub>-mediated signaling partially compensates for increased fEPSP half-width in Cdk5 KO mice.</title><p><italic>A</italic>, Effect of partial Na<sup>&#x0002b;</sup>-channel blockade on fEPSP amplitude. Representative fEPSPs traces from WT (red) and KO (black) are shown before and after TTX treatment (n&#x0200a;&#x0003d;&#x0200a;12). <italic>B</italic>, Increased basal fEPSP half-width in SC/CA1 pathway of KO hippocampus. Representative fEPSPs traces from WT (red) and KO (black) are shown with quantitation (n&#x0200a;&#x0003d;&#x0200a;9&#x02013;10). <italic>C</italic>, Representative fEPSPs traces before and after GABA<sub>A</sub> blockade (top) are shown with quantitation (bottom). Histograms show the changes in amplitude and half-width following treatment with 2 &#x000b5;M SR95531 (n&#x0200a;&#x0003d;&#x0200a;7). <italic>1</italic> and <italic>2</italic> indicate traces before and after treatment with SR95531, respectively. SR95531 had similar effects on fEPSP slope measurement. &#x0002a;P&#x0003c;0.05 vs. WT; <italic>post hoc t</italic>-test.</p></caption><graphic xlink:href="pone.0005808.g004"/></fig><p>Although the increase in NMDAR-mediated current in Cdk5 KO mice <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref> likely contributes to the neuronal hyperexcitability, additional mechanisms are also possible. Statistical analysis of basal synaptic responses in the SC/CA1 <italic>stratum radiatum</italic> layer in Mg<sup>&#x0002b;</sup>-containing conditions revealed that Cdk5 KO mice, 2&#x02013;4 weeks post-KO, had significantly longer fEPSP half-widths compared to WT mice (7.7&#x000b1;0.4 vs. 6.3&#x000b1;0.4 ms, respectively; <xref ref-type="fig" rid="pone-0005808-g004"><bold>Figure 4B</bold></xref>). This increase in fEPSP duration likely represents an impairment in repolarization and may contribute to increased neuronal excitability. Antagonism of NMDARs, Ca<sup>2&#x0002b;</sup> channels, and Na<sup>&#x0002b;</sup> channels did not reverse the elevated fEPSP half-width in Cdk5 KOs (not shown). Impairments in inhibitory signaling could result in behavioral hyperexcitability <xref ref-type="bibr" rid="pone.0005808-McNamara1">&#x0005b;27&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Fisher1">&#x0005b;35&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Mulley1">&#x0005b;36&#x0005d;</xref>. Therefore, the effects of GABA<sub>A</sub> channel antagonists on fEPSPs were measured. Administration of SR95531 led to equivalent increases in fEPSP amplitudes in WT and KO (20.1&#x000b1;5.2 vs. 25.1&#x000b1;12.1&#x00025; increase from baseline, respectively; <xref ref-type="fig" rid="pone-0005808-g004"><bold>Figure 4C</bold></xref>, left). However, SR95531 decreased the fEPSP half-width in WT but not KO slices (&#x02212;12.8&#x000b1;5.9&#x00025; vs. &#x0002b;5.9&#x000b1;1.7&#x00025; change, respectively; <xref ref-type="fig" rid="pone-0005808-g004"><bold>Figure 4C</bold></xref> right). These results suggest that GABA<sub>A</sub>-mediated signaling in Cdk5 KO mice may compensate for the increased fEPSP duration.</p></sec><sec id="s2g"><title>Increased behavioral seizure susceptibility follows chronic loss of Cdk5</title><p>Although NMDARs are critical for synaptic plasticity and learning, too much NMDAR activity may be harmful <xref ref-type="bibr" rid="pone.0005808-Hardingham1">&#x0005b;37&#x0005d;</xref>. During our studies, we found that prolonged loss of Cdk5 was associated with handling induced seizures and lethality when compared with controls. This observation prompted quantitative assessment of susceptibilities to handling-, pharmacologically-, and audiogenically-induced seizures. Hydroxytamoxifen-dosed <italic>Cre</italic> negative mice (WT) and vehicle-dosed animals carrying the <italic>Cre</italic> transgene alone displayed no spontaneous, handling-induced, or audiogenically-induced seizures. Furthermore, pharmacologically-induced behavioral seizure susceptibilities and latencies were equivalent between the vehicle-dosed and WT groups (not shown). On the other hand, chronic loss of Cdk5 led to handling-induced head nodding, wet dog shakes, or clonus behavioral seizures in 80&#x00025; of mice after 8 weeks of Cdk5 KO (<xref ref-type="fig" rid="pone-0005808-g005"><bold>Figure 5A</bold></xref>, top; <xref ref-type="table" rid="pone-0005808-t001"><bold>Table 1</bold></xref>). While mild handling induced Racine scale 1&#x02013;3 class seizures, more stressful conditions, such as water immersion, triggered Racine scale 3&#x02013;5 seizures, tonus and death in additional cohorts of chronic KO mice. Interestingly, increased seizure susceptibility correlated with lethality as loss of Cdk5 for 8 weeks and daily handling resulted in 40&#x00025; mortality (<xref ref-type="fig" rid="pone-0005808-g005"><bold>Figure 5A</bold></xref>, bottom; <xref ref-type="table" rid="pone-0005808-t001"><bold>Table 1</bold></xref>). In summary, chronic loss of Cdk5 led to increases susceptibility to handling-induced behavioral seizures and increases lethality.</p><fig id="pone-0005808-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005808.g005</object-id><label>Figure 5</label><caption><title>Elevated seizure susceptibility after chronic conditional Cdk5 loss.</title><p><italic>A</italic>, Kaplan-Meier seizure morbidity and survival curves. Percent of animals observed to have handling-induced seizures and percent survival are plotted against weeks post-KO; n&#x0200a;&#x0003d;&#x0200a;10&#x02013;14; the differences for morbidity and mortality were statistically significant, P&#x0003c;0.01, log-rank test. <italic>B</italic>, Latency to pilocarpine-induced wet-dog shakes (WDS), clonus (Cl), and rearing/falling (RF) seizures in mice, 8 weeks post-KO (n&#x0200a;&#x0003d;&#x0200a;7&#x02013;10). &#x0002a;P&#x0003c;0.05 vs. WT, Student's <italic>t-</italic>test. Data represent means&#x000b1;s.e.m. <italic>C&#x02013;F</italic>, Representative spontaneous EEG/EMG recordings from a conditional KO mouse, 8 weeks post-KO. <italic>C</italic>, Appearance of multiple bursts (at 3&#x02013;4 Hz) of spike waves which were frequently clustered as shown and accompanied by evident tremor and clonic seizures. <italic>D</italic>, Expanded view of 10 sec of the recording period shown in Figure <italic>C</italic>, displaying two spike bursts separated by about 2 sec. <italic>E</italic>, Post-ictally, there was rapid return to normal EEG/EMG and resumption of ongoing activity as displayed here during a period of wakefulness. <italic>F</italic>, Expanded view of 10 sec of the recording period shown in Figure <italic>E</italic>, Calibration 1 sec and 50 &#x000b5;V; the recording periods shown in panels <italic>D</italic> and <italic>F</italic> are annotated by the 10 sec bars in <italic>C</italic> and <italic>E</italic> respectively.</p></caption><graphic xlink:href="pone.0005808.g005"/></fig><table-wrap id="pone-0005808-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005808.t001</object-id><label>Table 1</label><caption><title>Long-term conditional Cdk5 knockout increases susceptibility to seizures.</title></caption><graphic id="pone-0005808-t001-1" xlink:href="pone.0005808.t001"/><table frame="hsides" rules="groups" alternate-form-of="pone-0005808-t001-1"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Category of seizures</td><td align="left" rowspan="1" colspan="1">genotype</td><td align="left" rowspan="1" colspan="1">Morbidity</td><td align="left" rowspan="1" colspan="1">Seizure latency (wks<xref ref-type="table-fn" rid="nt101">1</xref>)</td><td align="left" rowspan="1" colspan="1">Mortality<xref ref-type="table-fn" rid="nt102">2</xref></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Handling-induced</td><td align="left" rowspan="1" colspan="1">WT</td><td align="left" rowspan="1" colspan="1">0&#x00025; (0/12)</td><td align="left" rowspan="1" colspan="1">n/a</td><td align="left" rowspan="1" colspan="1">0&#x00025; (0/12)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">KO</td><td align="left" rowspan="1" colspan="1">80&#x00025; (8/10)</td><td align="left" rowspan="1" colspan="1">5.63&#x000b1;0.53</td><td align="left" rowspan="1" colspan="1">40&#x00025; (4/10)</td></tr><tr><td align="left" rowspan="1" colspan="1">Category of seizures</td><td align="left" rowspan="1" colspan="1">genotype</td><td align="left" rowspan="1" colspan="1">Clonus</td><td align="left" rowspan="1" colspan="1">Status epilepticus</td><td align="left" rowspan="1" colspan="1">Tonus &#x00026; Death</td></tr><tr><td align="left" rowspan="1" colspan="1">Chemically-induced<xref ref-type="table-fn" rid="nt103">3</xref></td><td align="left" rowspan="1" colspan="1">WT</td><td align="left" rowspan="1" colspan="1">71&#x00025; (5/7)</td><td align="left" rowspan="1" colspan="1">57&#x00025; (4/7)</td><td align="left" rowspan="1" colspan="1">42&#x00025; (3/7)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">KO</td><td align="left" rowspan="1" colspan="1">100&#x00025; (7/7)</td><td align="left" rowspan="1" colspan="1">100&#x00025; (7/7)</td><td align="left" rowspan="1" colspan="1">86&#x00025; (6/7)</td></tr></tbody></table><table-wrap-foot><fn id="nt101"><label>1</label><p>Weeks after last dose of hydroxytamoxifen.</p></fn><fn id="nt102"><label>2</label><p>Within 8 wks.</p></fn><fn id="nt103"><label>3</label><p>325 mg/kg pilocarpine, i.p./2.5 mg/kg scopolamine, <italic>s.c.</italic></p></fn></table-wrap-foot></table-wrap><p>To evaluate and quantify seizure susceptibility in Cdk5 KO mice, seizure latencies were scored after animals were treated with a convulsant, pilocarpine. Cdk5 KO mice displayed increased susceptibility (<xref ref-type="table" rid="pone-0005808-t001"><bold>Table 1</bold></xref>) and significantly shorter latencies than WT to undergo wet dog shakes (5.4&#x000b1;0.6 vs. 17.3&#x000b1;4.3 min, respectively), clonus (9.0&#x000b1;3.0 vs. 19.3&#x000b1;4.8 min), and rearing and falling (12.53&#x000b1;1.9 vs. 37.0&#x000b1;12.3 min; <xref ref-type="fig" rid="pone-0005808-g005"><bold>Figure 5B</bold></xref>). Hence, Cdk5 KO led to 68.7&#x00025;, 53.7&#x00025;, and 66.2&#x00025; decreases in mean latencies to induce wet dog shakes, clonus, and rearing and falling behavioral seizures. Chronic loss of Cdk5 led to increase central nervous system excitability exhibited by the decreased threshold for chemically-induced seizures.</p><p>Cranial electronencephalographic (EEG) electrodes and electromyographic (EMG) electrodes were implanted into mice and spontaneous activity was recorded for characterization of electrographic activity in WT versus Cdk5 KO mice. After loss of Cdk5 for 8 weeks, KO mice displayed epochs of multiple bursts (at 3&#x02013;4 Hz) of spike waves which correlated with tremor activity on EMG (<xref ref-type="fig" rid="pone-0005808-g005"><bold>Figure 5C&#x02013;D</bold></xref>). Post- and inter-ictally, there were normal EEG/EMG activities during wakefulness and sleep (<xref ref-type="fig" rid="pone-0005808-g005"><bold>Figure 5E&#x02013;F</bold></xref>). Seizure activity was not observed in littermate hydroxytamoxifen-dosed WT controls (<xref ref-type="supplementary-material" rid="pone.0005808.s001"><bold>Figure S1</bold></xref>). In summary, loss of Cdk5 for 2 months led to increased lethality, elevated seizure susceptibility, and electrographic evidence of seizure activity.</p></sec><sec id="s2h"><title>Increased acoustic startle reactivity in Cdk5 KO mice</title><p>As an additional study of behavioral excitability, the brainstem primary acoustic startle circuit was examined by measuring acoustic startle reactivity. Animals were exposed to auditory stimuli (white noise) at various decibels and startle responses were measured. Cdk5 KO startle responses were 1.8&#x000b1;0.6-, 2.2&#x000b1;0.5-, 2.5&#x000b1;0.4-, and 2.3&#x000b1;0.6-fold larger than WT after 90, 100, 110, and 120 db pulses, respectively (<xref ref-type="fig" rid="pone-0005808-g006"><bold>Figure 6A</bold></xref>). No differences between WT and KO were observed in habituation of startle responses (<xref ref-type="fig" rid="pone-0005808-g006"><bold>Figure 6B</bold></xref>) or pre-pulse acoustic inhibition (<xref ref-type="fig" rid="pone-0005808-g006"><bold>Figure 6C</bold></xref>). Thus, loss of Cdk5 in the adult brain elevated the acoustic startle responses but had no detectable difference on short-term acoustic habituation or pre-pulse inhibition.</p><fig id="pone-0005808-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005808.g006</object-id><label>Figure 6</label><caption><title>Increased acoustic startle reactivity with normal short-term acoustic habituation and prepulse inhibition in Cdk5 KO mice.</title><p><italic>A</italic>, Acoustic startle reactivity in Cdk5 KO mice (4&#x02013;8 weeks post-KO, n&#x0200a;&#x0003d;&#x0200a;17&#x02013;19). <italic>ANOVA</italic> revealed a main effect of genotype (F<sub>1,204</sub>&#x0200a;&#x0003d;&#x0200a;16.35, p&#x0003c;0.0001), decibels (F<sub>5,204</sub>&#x0200a;&#x0003d;&#x0200a;19.67, p&#x0003c;0.0001) and interaction between genotype and decibels (F<sub>5,204</sub>&#x0200a;&#x0003d;&#x0200a;3.72, p&#x0200a;&#x0003d;&#x0200a;0.003). &#x0002a;P&#x0003c;0.01, &#x0002a;&#x0002a;P&#x0003c;0.001, <sup>&#x02020;</sup>P&#x0200a;&#x0003d;&#x0200a;0.08 vs. WT, <italic>post hoc t</italic>-test. <italic>B</italic>, Habituation to a 120 db sound is shown as startle reactivity in three consecutive time blocks. <italic>ANOVA</italic> revealed effects of genotype (F<sub>1,68</sub>&#x0200a;&#x0003d;&#x0200a;8.62, p&#x0003c;0.006) and trial (F<sub>2,68</sub>&#x0200a;&#x0003d;&#x0200a;14.65, p&#x0003c;0.0001) but no interaction between genotype and trial (F<sub>2,68</sub>&#x0200a;&#x0003d;&#x0200a;0.31, p&#x0200a;&#x0003d;&#x0200a;0.7326). n&#x0200a;&#x0003d;&#x0200a;17&#x02013;19. <italic>C</italic>, Prepulse inhibition in Cdk5 KO mice. Prepulse at indicated decibels were given 5 ms prior to a 120 db sound. Prepulse inhibition is represented as percent decrease compared to an isolated 120 db sound. <italic>ANOVA</italic> revealed effect of decibel (F<sub>2,32</sub>&#x0200a;&#x0003d;&#x0200a;143.74, p&#x0003c;0.0001) but no effect of genotype (F<sub>1,32</sub>&#x0200a;&#x0003d;&#x0200a;2.03, p&#x0200a;&#x0003d;&#x0200a;0.1735) or interaction (F<sub>2,32</sub>&#x0200a;&#x0003d;&#x0200a;0.78, p&#x0200a;&#x0003d;&#x0200a;0.469). n&#x0200a;&#x0003d;&#x0200a;8&#x02013;10. Vehicle-treated animals behaved similarly to WT. Data represent mean&#x000b1;s.e.m.</p></caption><graphic xlink:href="pone.0005808.g006"/></fig></sec><sec id="s2i"><title>Audiogenic behavioral seizures after chronic loss of Cdk5</title><p>Audiogenic stimulation rarely produces seizures in healthy wild types animals. However, in special animal breeds, after kindling, or with certain genetic modifications, high-frequency acoustic tones can produce behavioral and electrographic seizure activity. While chemically-induced seizures are generally thought to model seizures of hippocampal or temporal lobe origin, audiogenic seizures may originate in the brainstem <xref ref-type="bibr" rid="pone.0005808-Pitkanen1">&#x0005b;29&#x0005d;</xref>. Given that loss of Cdk5 led to increases in acoustic startle reactivity, we examined whether loss of Cdk5 reduced the susceptibility to audiogenic seizures. Short-term loss of Cdk5 (2&#x02013;4 weeks) did not increase susceptibility to audiogenic behavioral seizures (0/10 short-term Cdk5 KO animals exhibited behavioral seizure activity). In contrast, prolonged loss of Cdk5 (for 8 weeks) increased susceptibility to audiogenically-induced seizures. High frequency audiogenic stimulation had no effect on WT but induced wild running in 37&#x00025; of KO mice in 32.3 sec (<xref ref-type="table" rid="pone-0005808-t002"><bold>Table 2</bold></xref>). Wild running progressed to tonic-clonic seizures and tonus followed by death in 18&#x00025; of KO animals within 56.0 sec. Consequently, chronic loss of Cdk5 in the adult brain increased the propensity towards acoustically-induced behavioral seizures.</p><table-wrap id="pone-0005808-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005808.t002</object-id><label>Table 2</label><caption><title>Audiogenic seizures after long-term conditional Cdk5 knockout<xref ref-type="table-fn" rid="nt104">1</xref>.</title></caption><graphic id="pone-0005808-t002-2" xlink:href="pone.0005808.t002"/><table frame="hsides" rules="groups" alternate-form-of="pone-0005808-t002-2"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Genotype</td><td colspan="2" align="left" rowspan="1">Wild Running</td><td colspan="2" align="left" rowspan="1">Tonic-clonic seizure</td><td colspan="2" align="left" rowspan="1">Tonus/death</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Morbidity</td><td align="left" rowspan="1" colspan="1">Latency (s)</td><td align="left" rowspan="1" colspan="1">Morbidity</td><td align="left" rowspan="1" colspan="1">Latency (s)</td><td align="left" rowspan="1" colspan="1">Morbidity</td><td align="left" rowspan="1" colspan="1">Latency (s)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">WT</td><td align="left" rowspan="1" colspan="1">0&#x00025; (0/10)</td><td align="left" rowspan="1" colspan="1">n/a</td><td align="left" rowspan="1" colspan="1">0&#x00025; (0/10)</td><td align="left" rowspan="1" colspan="1">n/a</td><td align="left" rowspan="1" colspan="1">0&#x00025; (0/10)</td><td align="left" rowspan="1" colspan="1">n/a</td></tr><tr><td align="left" rowspan="1" colspan="1">KO</td><td align="left" rowspan="1" colspan="1">27&#x00025; (3/11)</td><td align="left" rowspan="1" colspan="1">32.3&#x000b1;6.7</td><td align="left" rowspan="1" colspan="1">18&#x00025; (2/11)</td><td align="left" rowspan="1" colspan="1">50.0&#x000b1;11.0</td><td align="left" rowspan="1" colspan="1">18&#x00025; (2/11)</td><td align="left" rowspan="1" colspan="1">56.0&#x000b1;6.0</td></tr></tbody></table><table-wrap-foot><fn id="nt104"><label>1</label><p>After exposure to 90 db, 2.8 kHz pulse tone for 3 min</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2j"><title>Status epilepticus and electroconvulsive shock leads to the production of Cdk5-activating cofactor in the hippocampus</title><p>Both conditional KO of Cdk5 <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref> and transient overexpression of p25 <xref ref-type="bibr" rid="pone.0005808-Fischer1">&#x0005b;5&#x0005d;</xref> result in increased synaptic plasticity and learning. There may be common mechanistic features between loss of Cdk5 and diversion of Cdk5 to form a complex with p25. Interestingly, human hippocampal sclerosis is accompanied by p25 generation and altered Cdk5 activity <xref ref-type="bibr" rid="pone.0005808-Sen1">&#x0005b;38&#x0005d;</xref>. To further assess the role of Cdk5 in acute seizures and the homeostasis of neuronal excitability, status epilepticus was induced pharmacologically in WT mice and p25 levels were assessed in hippocampal lysates. Kainate-induced status epilepticus led to 5.0&#x000b1;2.7- and 3.9&#x000b1;1.3-fold increases in p25 level and p25/p35 ratio, respectively (<xref ref-type="fig" rid="pone-0005808-g007"><bold>Figure 7A</bold></xref>, left). Similarly, pilocarpine-induced status epilepticus caused 2.8&#x000b1;0.8- and 2.5&#x000b1;0.6-fold increases in p25 level and p25/p35 ratio (<xref ref-type="fig" rid="pone-0005808-g007"><bold>Figure 7A</bold></xref>, right). Hence, chemically-induced status epilepticus in normal WT animals caused p25 levels in increase in hippocampal lysates.</p><fig id="pone-0005808-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005808.g007</object-id><label>Figure 7</label><caption><title>p25 generation in the hippocampus after pharmacologically-induced status epilepticus and electroconvulsive shock.</title><p><italic>A</italic>, Representative immunoblots (top) and quantitation of p25 per tubulin (middle) and p25/35 ratio (bottom) after treatment with kainate and pilocarpine. VEH&#x0200a;&#x0003d;&#x0200a;saline; KA&#x0200a;&#x0003d;&#x0200a;kainate (50 mg/kg); SC&#x0200a;&#x0003d;&#x0200a;scopolamine (2 mg/kg)/saline; and SC/PI&#x0200a;&#x0003d;&#x0200a;scopolamine (2 mg/kg)/pilocarpine (280 mg/kg). n&#x0200a;&#x0003d;&#x0200a;4; &#x0002a;P&#x0003c;0.05 vs. VEH and SC in; Student's <italic>t-</italic>test. <italic>B</italic>, Representative immunoblots of p25 and quantitation of p25/p35 ratio 15, 30, and 60 min following electroconvulsive shock administration compared to unshocked controls (time&#x0200a;&#x0003d;&#x0200a;0); n&#x0200a;&#x0003d;&#x0200a;2. <italic>C</italic>, Hippocampal p25&#x02236;p35 ratio 6&#x02013;8 weeks post-KO. Crude lysates were immunoblotted for p25 and p35. Double asterisk indicates P&#x0003c;0.05 versus aged WT, Student's t-test; n&#x0200a;&#x0003d;&#x0200a;3&#x02013;4. Data represent means&#x000b1;s.e.m.</p></caption><graphic xlink:href="pone.0005808.g007"/></fig><p>Chemically-induced acute seizures only represents one of many models used to study seizures. Generation of p25 was also analyzed following electrical electroconvulsive shock. Electroconvulsive shock, which causes broad forebrain epileptiform activity, is clinically used to treat depression <xref ref-type="bibr" rid="pone.0005808-Fochtmann1">&#x0005b;39&#x0005d;</xref> and experimentally used for the generation of seizures <xref ref-type="bibr" rid="pone.0005808-Swinyard1">&#x0005b;40&#x0005d;</xref>. Acute electroconvulsive shock resulted in time-dependent accumulation in p25 in hippocampus (<xref ref-type="fig" rid="pone-0005808-g007"><bold>Figure 7B</bold></xref>). Sixty minutes following electroconvulsive shock, p25 levels increased 2.47&#x000b1;0.08-fold. The findings suggest that both pharmacologically- and electrically-induced epileptiform activity results in accumulation of the Cdk5 activating cofactor, p25.</p></sec><sec id="s2k"><title>Chronic but not acute loss of Cdk5 leads to reduced levels of Cdk5-activating cofactor in the hippocampus</title><p>Studies implicating Cdk5 and p25 in neuronal excitability suggest that Cdk5 may be activated in order to either attenuate or modulate excitability during seizures. Since Cdk5 KO mice displayed elevated neuronal excitability and susceptibility to seizures, we examined the levels of p25 in Cdk5 KO mice. Hippocampi from subacute Cdk5 KO mice (2&#x02013;4 weeks after KO) contained similar levels of p25 compared with controls (111.7&#x000b1;13.7&#x00025; of WT, p&#x0200a;&#x0003d;&#x0200a;0.6). However, chronic loss of Cdk5 for 6&#x02013;8 weeks led to a 58.4&#x000b1;12.4&#x00025; reduction in basal levels of p25 (<xref ref-type="fig" rid="pone-0005808-g007"><bold>Figure 7C</bold></xref>). Consequently, chronic but not acute loss of Cdk5 leads to reduced levels of p25. The decrease in p25 levels corresponds to an increase in neuronal excitability and seizure susceptibility.</p></sec></sec><sec id="s3"><title>Discussion</title><p>Previous studies have implicated Cdk5 in the regulation of neuronal excitability <xref ref-type="bibr" rid="pone.0005808-Benavides1">&#x0005b;1&#x0005d;</xref>. Cdk5 has been suggested to both increase <xref ref-type="bibr" rid="pone.0005808-Fletcher1">&#x0005b;41&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Shuang1">&#x0005b;42&#x0005d;</xref> and decrease <xref ref-type="bibr" rid="pone.0005808-Tomizawa1">&#x0005b;43&#x0005d;</xref> neurotransmitter release and modulate striatal neuron excitability <xref ref-type="bibr" rid="pone.0005808-Benavides1">&#x0005b;1&#x0005d;</xref>. Cdk5 has specifically been implicated in exocytosis and endocytosis via phosphorylation of numerous substrates including synapsin, amphiphysin I, dynamin, and others <xref ref-type="bibr" rid="pone.0005808-Cheng1">&#x0005b;44&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005808-Liang1">&#x0005b;47&#x0005d;</xref>. We previously demonstrated that conditional loss of Cdk5 led to enhancements in plasticity and learning via modulation of NMDAR degradation <xref ref-type="bibr" rid="pone.0005808-Meyer1">&#x0005b;9&#x0005d;</xref>. Furthermore, transient overexpression of Cdk5-activating cofactor, p25, increases NMDAR-mediated plasticity and synaptic transmission <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Hawasli2">&#x0005b;15&#x0005d;</xref>.</p><p>Here, we further characterize the enhancement of hippocampal plasticity in Cdk5 KO mice by studying fEPSPs during theta bursts and tetanic stimuli. We first show that within the SC/CA1 pathway, Cdk5 KO mice displayed altered LTP-inducing TBS topography. During the detailed LTP analyses, we find that loss of Cdk5 also leads to an NMDAR-independent enhancement in PTP, a presynaptic form of short-term plasticity. Although Cdk5 KO had no effect on paired pulse facilitation (PPF) with interstimulus intervals between 25 and 800 <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>, Cdk5 KO did lead to depression with a shorter 10 ms inter-stimulus interval. Cdk5 may theoretically confer these changes by increasing the number of presynaptic vesicles, increasing presynaptic Ca<sup>2&#x0002b;</sup>-influx, or increasing sensitivity to presynaptic Ca<sup>2&#x0002b;</sup>. Changes in probability of presynaptic vesicle release are usually accompanied by broad impairments in PPF. However, since loss of Cdk5 only conferred a PPF deficit at a very short interstimulus interval, additional information is necessary to better elucidate Cdk5&#x02032;s role in the presynapse. Although several studies implicate Cdk5 in vesicle release and recycling <xref ref-type="bibr" rid="pone.0005808-Fletcher1">&#x0005b;41&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005808-Tomizawa1">&#x0005b;43&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Tan1">&#x0005b;48&#x0005d;</xref>, the exact nature of Cdk5&#x02032;s role in the presynaptic compartment is still unclear. Future studies examining Cdk5&#x02032;s role in presynaptic terminal would be beneficial.</p><p>Conditional loss of Cdk5 initially leads to enhanced learning, plasticity and increased NMDAR-mediated currents <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>. In the present study, electrophysiological extracellular hippocampal recordings <italic>in vitro</italic> reveal that conditional loss of Cdk5 also leads to elevations in fEPSPs with a predominant NMDA component and reduced threshold for population-spike activity. It is known that the NR2B NMDAR subunit directly modulates neuronal excitability and contributes to seizures <xref ref-type="bibr" rid="pone.0005808-Mikuni1">&#x0005b;49&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005808-Ying1">&#x0005b;52&#x0005d;</xref>, so it is possible that a similar mechanism is involved following loss of Cdk5. Other mechanisms may also contribute to the enhanced hippocampal excitability. For example, loss of Cdk5 led to a subtle impairment in fEPSP repolarization in the hippocampal SC/CA1 pathway. Nonetheless, the data suggests that Cdk5 functions to attenuate hippocampal neuronal excitability via several mechanisms including the modulation of NMDARs.</p><p>Over time, Cdk5 KO mice displayed an increase in seizure susceptibility, suggesting a progressive increase in excitability. Chronic loss of Cdk5 increased the propensity for pharmacologically- and audiogenically-induced seizures. The reduced threshold for behavioral seizure activity correlated with EEG/EMG evidence of spontaneous seizures. Given the complexity, impact, and significance of spontaneous seizure activity, additional EEG recordings over an extended period of are warranted in future studies. In addition, conditional Cdk5 KO mice also displayed an increase in behavioral startle reactivity. We also found an association between the seizure phenotype and the lethality in Cdk5 KO mice: after 10 weeks of Cdk5 KO, the majority of Cdk5 KO mice displayed signs of increased behavioral excitability and propensity towards handling-induced seizures. Up to 40&#x00025; of affected mice died soon after displaying seizure activity.</p><p>The electrophysiological and behavioral experiments reveal similar trends. Initially, Cdk5 KO mice display increased NMDAR-mediated currents, enhanced plasticity, and impaired neuronal repolarization. Later, mice exhibit increased startle reactivity and reduced threshold for <italic>in vitro</italic> population spikes. Then, mice exhibit spontaneous electrographic seizures, handling-induced seizures, audiogenic seizures and lower threshold for pharmacologically-induced seizures. Although the experiments were performed at varying time-points after Cdk5 KO, together, the results suggest that loss of Cdk5 leads to a progressive increase in neuronal and behavioral excitability, ultimately leading to seizures.</p><p>Abnormal expression and dysregulation of Cdk5 and its cofactors have been demonstrated in tissues from human cortical dysplasia <xref ref-type="bibr" rid="pone.0005808-Sisodiya1">&#x0005b;53&#x0005d;</xref> and hippocampal sclerosis <xref ref-type="bibr" rid="pone.0005808-Sen1">&#x0005b;38&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Graham1">&#x0005b;46&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Sen2">&#x0005b;54&#x0005d;</xref>. KO of p35 leads to cortical lamination defects, seizures, and lethality <xref ref-type="bibr" rid="pone.0005808-Chae1">&#x0005b;55&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005808-Wenzel1">&#x0005b;57&#x0005d;</xref>. Mice lacking p35 also display abnormal morphological and functional organization of the hippocampus, dysplastic hippocampi, heterotopic pyramidal cells, and granule cell dispersion and may serve as a model for cortical dysplasia <xref ref-type="bibr" rid="pone.0005808-Pitkanen1">&#x0005b;29&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Wenzel1">&#x0005b;57&#x0005d;</xref>. In this study we show that chemically-induced status epilepticus and electroconvulsive shock in healthy animals induced acute generation of a Cdk5-activating cofactor, p25. Chronic loss of Cdk5 is associated with both seizures and reduced levels of p25. These published and new findings indicate that Cdk5 and its cofactors may play key regulatory roles in neuronal excitability.</p><p>Recent data have demonstrated dual roles for both Cdk5 and its activating cofactor, p25, in learning and plasticity <xref ref-type="bibr" rid="pone.0005808-Fischer1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>. A dichotomy may also exist for Cdk5/p25&#x02032;s role in pathological neuronal excitability associated with seizures. Loss of Cdk5 increases excitability and leads to seizures, which corresponds with decreased levels of p25. Acute seizures in healthy animals and chronic seizures in human epileptics produces elevated levels p25 <xref ref-type="bibr" rid="pone.0005808-Sen2">&#x0005b;54&#x0005d;</xref>. During periods of increased Ca<sup>2&#x0002b;</sup>-influx, neurons produce p25 following calpain activation <xref ref-type="bibr" rid="pone.0005808-Lee1">&#x0005b;58&#x0005d;</xref>. Initially, Cdk5/p25 may serve as a homeostatic molecule to dampen excitatory transmission and inhibit seizure activity. However, over-excitation could result in excessive Ca<sup>2&#x0002b;</sup>-influx and p25 generation, aberrant Cdk5 activity and neurotoxicity <xref ref-type="bibr" rid="pone.0005808-Ketelaars1">&#x0005b;59&#x0005d;</xref>. Thus, Cdk5 may serve to inhibit abnormal epileptiform activity when a neuron is in a normal state or promote cell death following excess and non-physiological Ca<sup>2&#x0002b;</sup> influx. We previously showed that Cdk5 facilitates calpain-mediated degradation of the NR2B NMDAR subunit <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>. Cdk5 KO may impair calpain-mediated p25 generation and thereby disrupt normal homeostatic mechanisms that prevent seizures. Future studies on Cdk5, calpain, p25, and NR2B may better our understanding of the divergent roles for Cdk5 in neuronal physiology and disease.</p><p>Current anticonvulsant therapeutics increase inhibitory neurotransmission, suppress high frequency neuronal firing by reducing voltage-gated Na<sup>&#x0002b;</sup> channels availability, or inhibit voltage-gated T-type Ca<sup>2&#x0002b;</sup>-channels. Such therapeutic options produce unwanted side effects, are only efficacious in 70&#x00025; of adults suffering from recurrent seizures <xref ref-type="bibr" rid="pone.0005808-Arroyo1">&#x0005b;60&#x0005d;</xref>, and generally alleviate the symptoms rather than curing or modifying the underlying etiology <xref ref-type="bibr" rid="pone.0005808-McNamara1">&#x0005b;27&#x0005d;</xref>. Aberrations in neuronal excitability can produce abnormal electrical discharges in the brain leading to seizure activity. Thus, a better understanding of the cellular mechanisms underlying neuronal excitability will aid in the development of novel therapeutics for seizures.</p><p>In future studies, it will be worthwhile to directly assess whether the increase in neuronal excitability following Cdk5 KO has any affects on presynaptic transmission, neuronal fiber sprouting, cell count, and cell survival. Furthermore, it would be interesting to study how long-term loss of Cdk5 affects hippocampal plasticity and learning. Although short-term loss of Cdk5 produced enhancements in plasticity and learning <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>, it is possible that chronic loss of Cdk5 and the associated epileptiform activity leads to neurodegeneration and impaired synaptogenesis, learning, and structural plasticity <xref ref-type="bibr" rid="pone.0005808-Fischer1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Sananbenesi1">&#x0005b;16&#x0005d;</xref>.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Animals and reagents</title><p>All procedures have been conducted in accordance with relevant NIH, national and international guidelines and were approved by the UT Southwestern Institutional Animal Care and Use Committees. Unless otherwise noted, mice were housed 4 per cage in a colony maintained at 23&#x000b0;C with a 12 h light/dark cycle (lights on from 7:00 A.M. to 7:00 P.M.) and <italic>ad libitum</italic> food and water. Breeding, genotyping, and KO induction were performed as previously described <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>. Adult mice were treated with 4-hydroxytamoxifen for 15 days (66.67 mg per kg, <italic>i.p.</italic>). Post-KO time period refers to the time following end of hydroxytamoxifen treatment. Hydroxytamoxifen-dosed mice with <italic>floxed Cdk5</italic> alleles mice served as WT littermate controls, as previously reported <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>. As additional controls, electrophysiolgical and behavioral experiments were also performed on genetic control strains: vehicle-dosed and undosed mice with and without <italic>Cre</italic> transgene and <italic>floxed Cdk5</italic> alleles. All experiments were performed on adult male mice with experimenter blind to genotype. Unless otherwise specified, reagents were purchased from Sigma.</p></sec><sec id="s4b"><title>Electrophysiological recordings</title><p>Transverse hippocampal slices from 8&#x02013;14 week old males were prepared in cutting saline (200 mM sucrose, 3 mM KCl, 1.4 mM NaH<sub>2</sub>PO<sub>4</sub>, 26 mM NaHCO<sub>3</sub>, 2 mM MgCl<sub>2</sub>, 2 mM CaCl<sub>2</sub>, 10 mM glucose) and maintained in an interface chamber containing artificial cerebrospinal fluid <xref ref-type="bibr" rid="pone.0005808-Cooper1">&#x0005b;61&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Fowler1">&#x0005b;62&#x0005d;</xref>. Extracellular field excitatory post-synpatic potentials (fEPSPs) in the Schaffer Collateral/CA1 hippocampal pathway (SC/CA1) were synaptically evoked at 0.033 Hz and recorded in the <italic>stratum pyramidale</italic> and <italic>stratum radiatum</italic> layers using a 64-channel array (150 &#x000b5;m interpolar distance, MED-P5155, Alpha MED Sciences). Input-output measurements were performed as described <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref> and, unless otherwise stated, fEPSPs were evoked using a stimulation intensity which elicited 50&#x00025; maximal response. Data acquisition and analysis were performed using the Multielectrode MED64 hardware and software packages (Panasonic) essentially as described <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>. Stimulus artifacts were removed and additional analyses were performed using custom macros running under Igor Pro, Microsoft Excel, and Graphpad Prism. LTP experiments were performed as described <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>. Theta burst topography was assessed 2&#x02013;4 weeks post Cdk5 KO as previously described <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Lauterborn1">&#x0005b;63&#x0005d;</xref>. fEPSP amplitudes in the <italic>stratum radiatum</italic> layer were measured with respect to the first fEPSP within each theta burst.</p></sec><sec id="s4c"><title>Post-tetanic potentiation</title><p>Post-tetanic potentiation was assessed as previously described, 2&#x02013;4 weeks post-KO <xref ref-type="bibr" rid="pone.0005808-Hawasli1">&#x0005b;7&#x0005d;</xref>. Basal input/output measurements were performed to determine stimulus intensity to elicit 40&#x00025; of the maximal fEPSP amplitude. Input/output analysis, paired-pulse facilitation, and tetani were performed in the absence of any drugs unless otherwise indicated. Post-tetanic potentiation (PTP) was elicited in the presence of 75 &#x000b5;M AP5. Baseline was followed by a brief 100 Hz tetanus <xref ref-type="bibr" rid="pone.0005808-Powell1">&#x0005b;23&#x0005d;</xref> and post-tetanus recordings. PTP measurements were made on the initial recording after the tetanus. Measurements of fEPSP slope showed similar results.</p></sec><sec id="s4d"><title>fEPSP measurements in Mg<sup>2&#x0002b;</sup>-free conditions and epileptiform activity</title><p>Mg<sup>2&#x0002b;</sup>-free fEPSP and epileptiform activity experiments were performed 4&#x02013;8 weeks post-KO. fEPSP input/output measurements were made in regular ACSF to determine the stimulation intensities required for 20&#x00025; and 100&#x00025; of maximal fEPSP amplitudes. Baseline and Mg<sup>2&#x0002b;</sup>-sensitive fEPSP amplitudes and areas were measured in regular ACSF and Mg<sup>2&#x0002b;</sup>-free ACSF, respectively. Mg<sup>2&#x0002b;</sup>-sensitive fEPSP measurements in the <italic>stratum radiatum</italic> were recorded using the 20&#x00025;-maximal stimulation intensity, which allowed for accurate measurement of fEPSP magnitude in the absence of population spikes and epileptiform activity. Any fEPSP measurements contaminated with population spikes were excluded from calculations. Evoked population spikes and epileptiform activity in the <italic>stratum pyramidale</italic> were recorded in Mg<sup>2&#x0002b;</sup>-free buffer. Input/output measurements were recorded in Mg<sup>2&#x0002b;</sup>-free buffer in triplicate and analyzed for population spikes. Fiber volley amplitude versus stimulus intensity was not significantly changed after washout of Mg<sup>2&#x0002b;</sup>. Maximum stimulation intensities were pre-determined by measuring the stimulus and fiber volley magnitudes necessary produced the maximum fEPSP magnitudes during basal input/output measurements. Stimulation intensities were binned and data was fit with a sigmoidal curve with R<sup>2</sup>&#x0003e;95&#x00025;.</p><p>Gross Na<sup>&#x0002b;</sup> channel function was assessed by calculating population spike threshold and measuring the effect of partial Na<sup>&#x0002b;</sup> channel blockade in normal ACSF. Traditional input/output measurement were performed in regular Mg<sup>2&#x0002b;</sup>-containing ACSF and visually analyzed for presence of population spikes in <italic>stratum radiatum</italic> and <italic>stratum pyramidale</italic>. Pecentage of slices displaying population spikes versus fiber volley amplitude was plotted. After input/output measurements, a stable baseline was recorded at 20&#x00025;-maximal stimulation. fEPSP magnitudes were measured after addition of 50 nM TTX. fEPSP amplitudes were plotted relative to baseline.</p></sec><sec id="s4e"><title>fEPSP repolarization</title><p>Repolarization experiments were performed 2&#x02013;4 weeks post-KO. Half-width was measured as the duration of fEPSP at the half-maximal amplitude in normal Mg<sup>2&#x0002b;</sup>-containing ACSF. To examine contributions of Na<sup>&#x0002b;</sup> channel, NMDAR, voltage-gated Ca<sup>2&#x0002b;</sup> channel, GABA<sub>A</sub>R-mediated synaptic transmission on fEPSP amplitudes, slopes, and half-widths, fEPSPs were measured before and after treatment with 50 nM tetrodotoxin (TTX), 75 &#x000b5;M AP5, 0.1 or 0.5 mM NiCl, and 2 &#x000b5;M SR95531, respectively.</p></sec><sec id="s4f"><title>Electronencephalographic (EEG)-Electromyographic (EMG) recordings</title><p>Adult male mice were surgically implanted for long-term EEG/EMG monitoring as previously described <xref ref-type="bibr" rid="pone.0005808-Chemelli1">&#x0005b;64&#x0005d;</xref>. Mice were anesthetized with a mixture containing 25 mg/ml ketamine and 2.5 mg/ml xylazine (administered i.p. at a dose of 0.1 mL/mouse). They were then held in a stereotaxic frame fitted with a mouse adaptor (David Kopf Instruments, Tujunga, CA). The cranium was exposed, cleaned of all connective tissue, and 4 burr holes were drilled, anterior and posterior to bregma, bilaterally (AP 1.1, ML&#x000b1;1.45 and AP &#x02212;3.5, ML&#x000b1;1.45). A prefabricated implant, with 4 EEG and 2 EMG electrodes, was then stereotaxically lowered and cemented to the skull using glass ionomer dental cement (Ketac-Cem Aplicap; ESPE, Norristown, PA). EMG wire electrodes were inserted contralaterally into the nuchal musculature using blunt dissection techniques. After suturing, the mouse was removed from the stereotaxic frame and allowed to recover from anesthesia. This design for the EEG/EMG implant allowed precise insertion of electrodes, targeting the frontal and occipital cortices at a consistent depth, just touching the dura, while minimizing surgical trauma.</p><p>EEG/EMG measurements were performed 8 weeks post-KO. Mice were housed individually under a 12 h light-dark cycle at 24&#x000b1;1&#x000b0;C, with standard laboratory chow (Harlan Teklad, Madison, WI) and water being replenished as necessary each day. Mice were not otherwise disturbed. They were habituated to these conditions for a week before EEG/EMG signals were recorded over 24 hour duration. Connections were made from the implanted cranial electrodes to the amplifier (Grass Model 78; Grass Instruments, West Warwick, RI) using a flexible, freely moving, lightweight cable. Amplified and filtered (EEG: 0.3&#x02013;100 Hz; EMG: 30&#x02013;300 Hz) signals were digitized at a sampling rate of 250 Hz, displayed using custom polygraph software, and archived for subsequent off-line analysis. Subsequently, the EEG/EMG record was visually screened for seizure epochs.</p></sec><sec id="s4g"><title>Seizures and startle response behaviors</title><p>All behavioral experiments were performed with two groups of 8&#x02013;14 week old males. The short-term KO group consisted of animals 2&#x02013;4 weeks after Cdk5 loss (<italic>i.e.</italic>, 2&#x02013;4 weeks following last does of hydroxytamoxifen). The chronic KO group consisted of animals 8 weeks following Cdk5 loss. Behavioral seizures were scored based on the Racine scale <xref ref-type="bibr" rid="pone.0005808-Pitkanen1">&#x0005b;29&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Racine1">&#x0005b;65&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Shah1">&#x0005b;66&#x0005d;</xref>. Seizure classes one through five were scored as mouth movements, head nodding or wet dog shakes, clonus, rearing, and rearing/falling, respectively. Behavioral seizure parameters such as wild running, tonic-clonic seizures, and tonus were also scored. To assess handling-induced seizures, animals which experienced daily handling were initially observed for signs of spontaneous seizures in home cage for 30 min and then assessed for 30 min after tail lift and scruffing. Handling-induced seizures typically included head nodding, clonus, or clonus with loss of balance. Chemically induced seizures were studied in mice 8-weeks post-KO. Animals were given scopolamine (2.75 mg/kg, <italic>s.c</italic>.) 5 min prior to pilocarpine (325 mg/kg, <italic>i.p.</italic>). Latency to and frequency of wet-dog shakes, clonus, tonus, rearing and falling and other seizures classes were recorded.</p><p>Startle response behaviors were studied 4&#x02013;8 weeks post-KO using the SR-Lab system (San Diego Instruments) as described <xref ref-type="bibr" rid="pone.0005808-Powell1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005808-Geyer1">&#x0005b;67&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005808-Kwon1">&#x0005b;69&#x0005d;</xref>. Audiogenic seizures were studied 2&#x02013;4 weeks and 8 weeks post-KO and induced in a plexiglass shock box with clear front and rear walls (MedAssociates). Mice were scored for baseline behavior for 3 min and scored for seizure activity during exposure to a 90 db, 2,800 Hz pulse tone for 3 min. Frequency of and latency to wild running, tonic-clonic seizures, tonus, other seizure stages, and death were recorded.</p></sec><sec id="s4h"><title>Pharmacologically-induced status epilepticus and electroconvulsive shock</title><p>Six-week old C57BL/6 (Charles River Labs) wild-type mice were injected with vehicle (saline, <italic>i.p.</italic>), kainate (50 mg/kg, <italic>i.p.</italic>; Tocris), scopolamine (2 mg/kg, <italic>s.c.</italic>)/saline (<italic>i.p.</italic>), or scopolamine (2 mg/kg, <italic>s.c.</italic>)/pilocarpine (280 mg/kg, <italic>i.p.</italic>). Scopolamine was injected 5 min prior to pilocarpine. Animals were scored for latencies to and frequencies of seizure stages including head nodding, wet dog shakes, forelimb clonus, tonic-clonic seizures, rearing, and, rearing/falling. Hippocampi were dissected 25 min after first robust episode of rearing/falling, flash frozen, and stored at minus 80&#x000b0;C.</p><p>Electroconvulsive shock (ECS) was administered to adult male Sprague&#x02013;Dawley rats (175&#x02013;200 g) by delivering a current of 50 mA for 0.3 sec via bilateral ear clips essentially as described <xref ref-type="bibr" rid="pone.0005808-Gold1">&#x0005b;70&#x0005d;</xref>. Hippocampi were dissected at the specified time-points after stimulation, flash frozen, and stored at minus 80&#x000b0;C. Animals which did not receive the shock served as controls.</p></sec><sec id="s4i"><title>Immunoblot analysis</title><p>Frozen samples were sonicated in boiling 1&#x00025; SDS containing 50 mM NaF and boiled for an additional 5 min. Protein concentrations were determined by the BCA protein assay (Pierce) using bovine serum albumin standards. An equal amount of total protein (100 &#x000b5;g) from each sample was subjected to SDS-PAGE followed by electrophoretic transfer to nitrocellulose membranes (Whatman). The membranes were immunoblotted using antibodies for p35/p25 (1&#x02236;200; C-19 Santa Cruz) and alpha-tubulin (1&#x02236;5000), followed by incubation with a horseradish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibody (1&#x02236;8000; Chemicon). Antibody binding was detected by autoradiography using the enhanced chemiluminescence immunoblotting detection system (Amersham Biosciences) and quantified by densitometry using Image J software (NIH).</p></sec><sec id="s4j"><title>Statistical analysis</title><p>All data was represented at mean&#x000b1;s.e.m. Errors for fold changes were calculated using standard error propagation rules. Differences between data groups were evaluated for significance using analysis of variance (<italic>ANOVA</italic>) with <italic>post hoc t</italic>-tests and statistical significance was set to p&#x0003c;0.05.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0005808.s001"><label>Figure S1</label><caption><p>Representative EEG/EMG recordings from a wild-type control mouse. A, A period of normal wakefulness. B, Expanded view of 10 sec of the recording period shown in A. Calibration 1 sec and 50 &#x000b5;V; the recording period shown in panel B is annotated by the 10 sec bar in A.</p><p>(0.19 MB TIF)</p></caption><media xlink:href="pone.0005808.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Shiori Ogawa, David R. Benavides, Janice W. Kansy, Jennifer Pick, Shari G. Birnbaum, Stephan J. Gold (Merck Research Laboratories), Paul Greengard (The Rockefeller University), and the Medical Scientist Training Program at University of Texas Southwestern Medical Center.</p></ack><ref-list><title>References</title><ref id="pone.0005808-Benavides1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benavides</surname><given-names>DR</given-names></name><name><surname>Quinn</surname><given-names>JJ</given-names></name><name><surname>Zhong</surname><given-names>P</given-names></name><name><surname>Hawasli</surname><given-names>AH</given-names></name><name><surname>DiLeone</surname><given-names>RJ</given-names></name><etal/></person-group><year>2007</year><article-title>Cdk5 modulates cocaine reward, motivation, and striatal neuron excitability.</article-title><source>J Neurosci</source><volume>27</volume><fpage>12967</fpage><lpage>12976</lpage><pub-id pub-id-type="pmid">18032670</pub-id></citation></ref><ref id="pone.0005808-Bibb1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bibb</surname><given-names>JA</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Taylor</surname><given-names>JR</given-names></name><name><surname>Svenningsson</surname><given-names>P</given-names></name><name><surname>Nishi</surname><given-names>A</given-names></name><etal/></person-group><year>2001</year><article-title>Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.</article-title><source>Nature</source><volume>410</volume><fpage>376</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">11268215</pub-id></citation></ref><ref id="pone.0005808-Bibb2"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bibb</surname><given-names>JA</given-names></name><name><surname>Snyder</surname><given-names>GL</given-names></name><name><surname>Nishi</surname><given-names>A</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Meijer</surname><given-names>L</given-names></name><etal/></person-group><year>1999</year><article-title>Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.</article-title><source>Nature</source><volume>402</volume><fpage>669</fpage><lpage>671</lpage><pub-id pub-id-type="pmid">10604473</pub-id></citation></ref><ref id="pone.0005808-Cheung1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>ZH</given-names></name><name><surname>Fu</surname><given-names>AKY</given-names></name><name><surname>Ip</surname><given-names>NY</given-names></name></person-group><year>2006</year><article-title>Synaptic Roles of Cdk5: Implications in Higher Cognitive Functions and Neurodegenerative Diseases.</article-title><source>Neuron</source><volume>50</volume><fpage>13</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">16600851</pub-id></citation></ref><ref id="pone.0005808-Fischer1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>A</given-names></name><name><surname>Sananbenesi</surname><given-names>F</given-names></name><name><surname>Pang</surname><given-names>PT</given-names></name><name><surname>Lu</surname><given-names>B</given-names></name><name><surname>Tsai</surname><given-names>LH</given-names></name></person-group><year>2005</year><article-title>Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory.</article-title><source>Neuron</source><volume>48</volume><fpage>825</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">16337919</pub-id></citation></ref><ref id="pone.0005808-Gilmore1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilmore</surname><given-names>EC</given-names></name><name><surname>Ohshima</surname><given-names>T</given-names></name><name><surname>Goffinet</surname><given-names>AM</given-names></name><name><surname>Kulkarni</surname><given-names>AB</given-names></name><name><surname>Herrup</surname><given-names>K</given-names></name></person-group><year>1998</year><article-title>Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex.</article-title><source>J Neurosci</source><volume>18</volume><fpage>6370</fpage><lpage>6377</lpage><pub-id pub-id-type="pmid">9698328</pub-id></citation></ref><ref id="pone.0005808-Hawasli1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawasli</surname><given-names>AH</given-names></name><name><surname>Benavides</surname><given-names>DR</given-names></name><name><surname>Nguyen</surname><given-names>C</given-names></name><name><surname>Kansy</surname><given-names>JW</given-names></name><name><surname>Hayash</surname><given-names>K</given-names></name><etal/></person-group><year>2007</year><article-title>Cyclin-dependent kinase 5 governs learning and synaptic plasticity via regulation of NMDA receptor degradation.</article-title><source>Nature Neuroscience</source><volume>10</volume><fpage>880</fpage><lpage>886</lpage></citation></ref><ref id="pone.0005808-Lagace1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lagace</surname><given-names>DC</given-names></name><name><surname>Benavides</surname><given-names>DR</given-names></name><name><surname>Kansy</surname><given-names>JW</given-names></name><name><surname>Mapelli</surname><given-names>M</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name><etal/></person-group><year>2008</year><article-title>Cdk5 is essential for adult hippocampal neurogenesis.</article-title><source>Proc Natl Acad Sci U S A</source><volume>105</volume><fpage>18567</fpage><lpage>18571</lpage><pub-id pub-id-type="pmid">19017796</pub-id></citation></ref><ref id="pone.0005808-Meyer1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>DA</given-names></name><name><surname>Richer</surname><given-names>E</given-names></name><name><surname>Benkovic</surname><given-names>SA</given-names></name><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>Kansy</surname><given-names>JW</given-names></name><etal/></person-group><year>2008</year><article-title>Striatal dysregulation of Cdk5 alters locomotor responses to cocaine, motor learning, and dendritic morphology.</article-title><source>Proc Natl Acad Sci U S A</source><volume>105</volume><fpage>18561</fpage><lpage>18566</lpage><pub-id pub-id-type="pmid">19017804</pub-id></citation></ref><ref id="pone.0005808-Ohshima1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohshima</surname><given-names>T</given-names></name><name><surname>Ogura</surname><given-names>H</given-names></name><name><surname>Tomizawa</surname><given-names>K</given-names></name><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><etal/></person-group><year>2005</year><article-title>Impairment of hippocampal long-term depression and defective spatial learning and memory in p35 mice.</article-title><source>J Neurochem</source><volume>94</volume><fpage>917</fpage><lpage>925</lpage><pub-id pub-id-type="pmid">15992381</pub-id></citation></ref><ref id="pone.0005808-Ohshima2"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohshima</surname><given-names>T</given-names></name><name><surname>Ward</surname><given-names>JM</given-names></name><name><surname>Huh</surname><given-names>CG</given-names></name><name><surname>Longenecker</surname><given-names>G</given-names></name><name><surname>Veeranna</surname></name><etal/></person-group><year>1996</year><article-title>Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.</article-title><source>Proc Natl Acad Sci U S A</source><volume>93</volume><fpage>11173</fpage><lpage>11178</lpage><pub-id pub-id-type="pmid">8855328</pub-id></citation></ref><ref id="pone.0005808-Patrick1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patrick</surname><given-names>GN</given-names></name><name><surname>Zukerberg</surname><given-names>L</given-names></name><name><surname>Nikolic</surname><given-names>M</given-names></name><name><surname>de la Monte</surname><given-names>S</given-names></name><name><surname>Dikkes</surname><given-names>P</given-names></name><etal/></person-group><year>1999</year><article-title>Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.</article-title><source>Nature</source><volume>402</volume><fpage>615</fpage><lpage>622</lpage><pub-id pub-id-type="pmid">10604467</pub-id></citation></ref><ref id="pone.0005808-Sahin1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sahin</surname><given-names>B</given-names></name><name><surname>Hawasli</surname><given-names>AH</given-names></name><name><surname>Greene</surname><given-names>RW</given-names></name><name><surname>Molkentin</surname><given-names>JD</given-names></name><name><surname>Bibb</surname><given-names>JA</given-names></name></person-group><year>2008</year><article-title>Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C.</article-title><source>Eur J Pharmacol</source><volume>581</volume><fpage>270</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">18190909</pub-id></citation></ref><ref id="pone.0005808-Wei1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>FY</given-names></name><name><surname>Tomizawa</surname><given-names>K</given-names></name><name><surname>Ohshima</surname><given-names>T</given-names></name><name><surname>Asada</surname><given-names>A</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><etal/></person-group><year>2005</year><article-title>Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability.</article-title><source>J Neurochem</source><volume>93</volume><fpage>502</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">15816873</pub-id></citation></ref><ref id="pone.0005808-Hawasli2"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawasli</surname><given-names>AH</given-names></name><name><surname>Bibb</surname><given-names>JA</given-names></name></person-group><year>2007</year><article-title>Alternative roles for Cdk5 in learning and synaptic plasticity.</article-title><source>Biotechnol J</source><volume>2</volume><fpage>941</fpage><lpage>948</lpage><pub-id pub-id-type="pmid">17597494</pub-id></citation></ref><ref id="pone.0005808-Sananbenesi1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sananbenesi</surname><given-names>F</given-names></name><name><surname>Fischer</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Schrick</surname><given-names>C</given-names></name><name><surname>Neve</surname><given-names>R</given-names></name><etal/></person-group><year>2007</year><article-title>A hippocampal Cdk5 pathway regulates extinction of contextual fear.</article-title><source>Nat Neurosci</source><volume>10</volume><fpage>1012</fpage><lpage>1019</lpage><pub-id pub-id-type="pmid">17632506</pub-id></citation></ref><ref id="pone.0005808-Fischer2"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>A</given-names></name><name><surname>Sananbenesi</surname><given-names>F</given-names></name><name><surname>Schrick</surname><given-names>C</given-names></name><name><surname>Spiess</surname><given-names>J</given-names></name><name><surname>Radulovic</surname><given-names>J</given-names></name></person-group><year>2002</year><article-title>Cyclin-dependent kinase 5 is required for associative learning.</article-title><source>J Neurosci</source><volume>22</volume><fpage>3700</fpage><lpage>3707</lpage><pub-id pub-id-type="pmid">11978846</pub-id></citation></ref><ref id="pone.0005808-Bibb3"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bibb</surname><given-names>JA</given-names></name></person-group><year>2003</year><article-title>Role of Cdk5 in neuronal signaling, plasticity, and drug abuse.</article-title><source>Neurosignals</source><volume>12</volume><fpage>191</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">14673205</pub-id></citation></ref><ref id="pone.0005808-Cruz1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>JC</given-names></name><name><surname>Tsai</surname><given-names>LH</given-names></name></person-group><year>2004</year><article-title>Cdk5 deregulation in the pathogenesis of Alzheimer's disease.</article-title><source>Trends Mol Med</source><volume>10</volume><fpage>452</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">15350898</pub-id></citation></ref><ref id="pone.0005808-Simpkins1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simpkins</surname><given-names>KL</given-names></name><name><surname>Guttmann</surname><given-names>RP</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Sokol</surname><given-names>S</given-names></name><etal/></person-group><year>2003</year><article-title>Selective activation induced cleavage of the NR2B subunit by calpain.</article-title><source>J Neurosci</source><volume>23</volume><fpage>11322</fpage><lpage>11331</lpage><pub-id pub-id-type="pmid">14672996</pub-id></citation></ref><ref id="pone.0005808-Yan1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Chi</surname><given-names>P</given-names></name><name><surname>Bibb</surname><given-names>JA</given-names></name><name><surname>Ryan</surname><given-names>TA</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name></person-group><year>2002</year><article-title>Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons.</article-title><source>J Physiol</source><volume>540</volume><fpage>761</fpage><lpage>770</lpage><pub-id pub-id-type="pmid">11986366</pub-id></citation></ref><ref id="pone.0005808-Buraei1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buraei</surname><given-names>Z</given-names></name><name><surname>Schofield</surname><given-names>G</given-names></name><name><surname>Elmslie</surname><given-names>KS</given-names></name></person-group><year>2007</year><article-title>Roscovitine differentially affects CaV2 and Kv channels by binding to the open state.</article-title><source>Neuropharmacology</source><volume>52</volume><fpage>883</fpage><lpage>894</lpage><pub-id pub-id-type="pmid">17125805</pub-id></citation></ref><ref id="pone.0005808-Powell1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname><given-names>CM</given-names></name><name><surname>Schoch</surname><given-names>S</given-names></name><name><surname>Monteggia</surname><given-names>L</given-names></name><name><surname>Barrot</surname><given-names>M</given-names></name><name><surname>Matos</surname><given-names>MF</given-names></name><etal/></person-group><year>2004</year><article-title>The presynaptic active zone protein RIM1alpha is critical for normal learning and memory.</article-title><source>Neuron</source><volume>42</volume><fpage>143</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">15066271</pub-id></citation></ref><ref id="pone.0005808-Weber1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>P</given-names></name><name><surname>Metzger</surname><given-names>D</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name></person-group><year>2001</year><article-title>Temporally controlled targeted somatic mutagenesis in the mouse brain.</article-title><source>Eur J Neurosci</source><volume>14</volume><fpage>1777</fpage><lpage>1783</lpage><pub-id pub-id-type="pmid">11860472</pub-id></citation></ref><ref id="pone.0005808-Kramar1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kramar</surname><given-names>EA</given-names></name><name><surname>Lin</surname><given-names>B</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name><name><surname>Arai</surname><given-names>AC</given-names></name><name><surname>Gall</surname><given-names>CM</given-names></name><etal/></person-group><year>2004</year><article-title>A novel mechanism for the facilitation of theta-induced long-term potentiation by brain-derived neurotrophic factor.</article-title><source>J Neurosci</source><volume>24</volume><fpage>5151</fpage><lpage>5161</lpage><pub-id pub-id-type="pmid">15175384</pub-id></citation></ref><ref id="pone.0005808-Kamiya1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamiya</surname><given-names>H</given-names></name><name><surname>Zucker</surname><given-names>RS</given-names></name></person-group><year>1994</year><article-title>Residual Ca2&#x0002b; and short-term synaptic plasticity.</article-title><source>Nature</source><volume>371</volume><fpage>603</fpage><lpage>606</lpage><pub-id pub-id-type="pmid">7935792</pub-id></citation></ref><ref id="pone.0005808-McNamara1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McNamara</surname><given-names>JO</given-names></name><name><surname>Huang</surname><given-names>YZ</given-names></name><name><surname>Leonard</surname><given-names>AS</given-names></name></person-group><year>2006</year><article-title>Molecular signaling mechanisms underlying epileptogenesis.</article-title><source>Sci STKE</source><volume>2006</volume><fpage>re12</fpage><pub-id pub-id-type="pmid">17033045</pub-id></citation></ref><ref id="pone.0005808-Ohmori1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohmori</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Namiki</surname><given-names>A</given-names></name></person-group><year>2004</year><article-title>The anticonvulsant action of propofol on epileptiform activity in rat hippocampal slices.</article-title><source>Anesth Analg</source><volume>99</volume><fpage>1095</fpage><lpage>1101</lpage><comment>table of contents</comment><pub-id pub-id-type="pmid">15385357</pub-id></citation></ref><ref id="pone.0005808-Pitkanen1"><label>29</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Pitkanen</surname><given-names>A</given-names></name><name><surname>Schwartzhroin</surname><given-names>PA</given-names></name><name><surname>Moshe</surname><given-names>SL</given-names></name></person-group><year>2006</year><source>Models of Seizures and Epilepsy</source><publisher-loc>Oxford</publisher-loc><publisher-name>Elsevier</publisher-name><fpage>687</fpage></citation></ref><ref id="pone.0005808-Baulac1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baulac</surname><given-names>S</given-names></name><name><surname>Gourfinkel-An</surname><given-names>I</given-names></name><name><surname>Picard</surname><given-names>F</given-names></name><name><surname>Rosenberg-Bourgin</surname><given-names>M</given-names></name><name><surname>Prud'homme</surname><given-names>JF</given-names></name><etal/></person-group><year>1999</year><article-title>A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33.</article-title><source>Am J Hum Genet</source><volume>65</volume><fpage>1078</fpage><lpage>1085</lpage><pub-id pub-id-type="pmid">10486327</pub-id></citation></ref><ref id="pone.0005808-Escayg1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Escayg</surname><given-names>A</given-names></name><name><surname>Heils</surname><given-names>A</given-names></name><name><surname>MacDonald</surname><given-names>BT</given-names></name><name><surname>Haug</surname><given-names>K</given-names></name><name><surname>Sander</surname><given-names>T</given-names></name><etal/></person-group><year>2001</year><article-title>A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus&#x02014;nd prevalence of variants in patients with epilepsy.</article-title><source>Am J Hum Genet</source><volume>68</volume><fpage>866</fpage><lpage>873</lpage><pub-id pub-id-type="pmid">11254445</pub-id></citation></ref><ref id="pone.0005808-Escayg2"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Escayg</surname><given-names>A</given-names></name><name><surname>MacDonald</surname><given-names>BT</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name><name><surname>Baulac</surname><given-names>S</given-names></name><name><surname>Huberfeld</surname><given-names>G</given-names></name><etal/></person-group><year>2000</year><article-title>Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS&#x0002b;2.</article-title><source>Nat Genet</source><volume>24</volume><fpage>343</fpage><lpage>345</lpage><pub-id pub-id-type="pmid">10742094</pub-id></citation></ref><ref id="pone.0005808-Wallace1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>RH</given-names></name><name><surname>Wang</surname><given-names>DW</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Scheffer</surname><given-names>IE</given-names></name><name><surname>George</surname><given-names>AL</given-names><suffix>Jr</suffix></name><etal/></person-group><year>1998</year><article-title>Febrile seizures and generalized epilepsy associated with a mutation in the Na&#x0002b;-channel beta1 subunit gene SCN1B.</article-title><source>Nat Genet</source><volume>19</volume><fpage>366</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">9697698</pub-id></citation></ref><ref id="pone.0005808-Madeja1"><label>34</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Madeja</surname><given-names>M</given-names></name></person-group><year>2000</year><article-title>Do neurons have a reserve of sodium channels for the generation of action potentials? A study on acutely isolated CA1 neurons from the guinea-pig hippocampus.</article-title><source>Eur J Neurosci</source><volume>12</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10651854</pub-id></citation></ref><ref id="pone.0005808-Fisher1"><label>35</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>RS</given-names></name><name><surname>Coyle</surname><given-names>JT</given-names></name></person-group><year>1991</year><source>Neurotransmitters and epilepsy</source><publisher-loc>New York</publisher-loc><publisher-name>Wiley-Liss</publisher-name></citation></ref><ref id="pone.0005808-Mulley1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulley</surname><given-names>JC</given-names></name><name><surname>Scheffer</surname><given-names>IE</given-names></name><name><surname>Petrou</surname><given-names>S</given-names></name><name><surname>Berkovic</surname><given-names>SF</given-names></name></person-group><year>2003</year><article-title>Channelopathies as a genetic cause of epilepsy.</article-title><source>Curr Opin Neurol</source><volume>16</volume><fpage>171</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">12644745</pub-id></citation></ref><ref id="pone.0005808-Hardingham1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hardingham</surname><given-names>GE</given-names></name><name><surname>Bading</surname><given-names>H</given-names></name></person-group><year>2003</year><article-title>The Yin and Yang of NMDA receptor signalling.</article-title><source>Trends Neurosci</source><volume>26</volume><fpage>81</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">12536131</pub-id></citation></ref><ref id="pone.0005808-Sen1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>A</given-names></name><name><surname>Thom</surname><given-names>M</given-names></name><name><surname>Martinian</surname><given-names>L</given-names></name><name><surname>Jacobs</surname><given-names>T</given-names></name><name><surname>Nikolic</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>Deregulation of cdk5 in Hippocampal sclerosis.</article-title><source>J Neuropathol Exp Neurol</source><volume>65</volume><fpage>55</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">16410749</pub-id></citation></ref><ref id="pone.0005808-Fochtmann1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fochtmann</surname><given-names>LJ</given-names></name></person-group><year>1994</year><article-title>Animal studies of electroconvulsive therapy: foundations for future research.</article-title><source>Psychopharmacol Bull</source><volume>30</volume><fpage>321</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">7878180</pub-id></citation></ref><ref id="pone.0005808-Swinyard1"><label>40</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Swinyard</surname><given-names>EA</given-names></name></person-group><year>1972</year><article-title>Electrically induced convulsions.</article-title><person-group person-group-type="editor"><name><surname>Purpura</surname><given-names>DP</given-names></name><name><surname>Penry</surname><given-names>D</given-names></name><name><surname>Tower</surname><given-names>DW</given-names></name><name><surname>D</surname><given-names>M</given-names></name><name><surname>Walter</surname><given-names>R</given-names></name></person-group><source>Experimental Models of Epilepsy</source><publisher-loc>New York</publisher-loc><publisher-name>Raven Press</publisher-name><fpage>433</fpage><lpage>458</lpage></citation></ref><ref id="pone.0005808-Fletcher1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>AI</given-names></name><name><surname>Shuang</surname><given-names>R</given-names></name><name><surname>Giovannucci</surname><given-names>DR</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Bittner</surname><given-names>MA</given-names></name><etal/></person-group><year>1999</year><article-title>Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18.</article-title><source>J Biol Chem</source><volume>274</volume><fpage>4027</fpage><lpage>4035</lpage><pub-id pub-id-type="pmid">9933594</pub-id></citation></ref><ref id="pone.0005808-Shuang1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shuang</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Fletcher</surname><given-names>A</given-names></name><name><surname>Groblewski</surname><given-names>GE</given-names></name><name><surname>Pevsner</surname><given-names>J</given-names></name><etal/></person-group><year>1998</year><article-title>Regulation of Munc-18/syntaxin 1A interaction by cyclin-dependent kinase 5 in nerve endings.</article-title><source>J Biol Chem</source><volume>273</volume><fpage>4957</fpage><lpage>4966</lpage><pub-id pub-id-type="pmid">9478941</pub-id></citation></ref><ref id="pone.0005808-Tomizawa1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomizawa</surname><given-names>K</given-names></name><name><surname>Ohta</surname><given-names>J</given-names></name><name><surname>Matsushita</surname><given-names>M</given-names></name><name><surname>Moriwaki</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>ST</given-names></name><etal/></person-group><year>2002</year><article-title>Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity.</article-title><source>J Neurosci</source><volume>22</volume><fpage>2590</fpage><lpage>2597</lpage><pub-id pub-id-type="pmid">11923424</pub-id></citation></ref><ref id="pone.0005808-Cheng1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>K</given-names></name><name><surname>Ip</surname><given-names>NY</given-names></name></person-group><year>2003</year><article-title>Cdk5: a new player at synapses.</article-title><source>Neurosignals</source><volume>12</volume><fpage>180</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">14673204</pub-id></citation></ref><ref id="pone.0005808-Evans1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>GJ</given-names></name><name><surname>Cousin</surname><given-names>MA</given-names></name></person-group><year>2007</year><article-title>Activity-dependent control of slow synaptic vesicle endocytosis by cyclin-dependent kinase 5.</article-title><source>J Neurosci</source><volume>27</volume><fpage>401</fpage><lpage>411</lpage><pub-id pub-id-type="pmid">17215401</pub-id></citation></ref><ref id="pone.0005808-Graham1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>ME</given-names></name><name><surname>Anggono</surname><given-names>V</given-names></name><name><surname>Bache</surname><given-names>N</given-names></name><name><surname>Larsen</surname><given-names>MR</given-names></name><name><surname>Craft</surname><given-names>GE</given-names></name><etal/></person-group><year>2007</year><article-title>The in vivo phosphorylation sites of rat brain dynamin I. J Biol Chem</article-title><volume>282</volume><fpage>14695</fpage><lpage>14707</lpage></citation></ref><ref id="pone.0005808-Liang1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>FY</given-names></name><name><surname>Wu</surname><given-names>YM</given-names></name><name><surname>Tanabe</surname><given-names>K</given-names></name><name><surname>Abe</surname><given-names>T</given-names></name><etal/></person-group><year>2007</year><article-title>Major Cdk5-dependent phosphorylation sites of amphiphysin 1 are implicated in the regulation of the membrane binding and endocytosis.</article-title><source>J Neurochem</source></citation></ref><ref id="pone.0005808-Tan1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>TC</given-names></name><name><surname>Valova</surname><given-names>VA</given-names></name><name><surname>Malladi</surname><given-names>CS</given-names></name><name><surname>Graham</surname><given-names>ME</given-names></name><name><surname>Berven</surname><given-names>LA</given-names></name><etal/></person-group><year>2003</year><article-title>Cdk5 is essential for synaptic vesicle endocytosis.</article-title><source>Nat Cell Biol</source><volume>5</volume><fpage>701</fpage><lpage>710</lpage><pub-id pub-id-type="pmid">12855954</pub-id></citation></ref><ref id="pone.0005808-Mikuni1"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mikuni</surname><given-names>N</given-names></name><name><surname>Babb</surname><given-names>TL</given-names></name><name><surname>Ying</surname><given-names>Z</given-names></name><name><surname>Najm</surname><given-names>I</given-names></name><name><surname>Nishiyama</surname><given-names>K</given-names></name><etal/></person-group><year>1999</year><article-title>NMDA-receptors 1 and 2A/B coassembly increased in human epileptic focal cortical dysplasia.</article-title><source>Epilepsia</source><volume>40</volume><fpage>1683</fpage><lpage>1687</lpage><pub-id pub-id-type="pmid">10612330</pub-id></citation></ref><ref id="pone.0005808-Moddel1"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moddel</surname><given-names>G</given-names></name><name><surname>Jacobson</surname><given-names>B</given-names></name><name><surname>Ying</surname><given-names>Z</given-names></name><name><surname>Janigro</surname><given-names>D</given-names></name><name><surname>Bingaman</surname><given-names>W</given-names></name><etal/></person-group><year>2005</year><article-title>The NMDA receptor NR2B subunit contributes to epileptogenesis in human cortical dysplasia.</article-title><source>Brain Res</source><volume>1046</volume><fpage>10</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">15890316</pub-id></citation></ref><ref id="pone.0005808-Najm1"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Najm</surname><given-names>IM</given-names></name><name><surname>Ying</surname><given-names>Z</given-names></name><name><surname>Babb</surname><given-names>T</given-names></name><name><surname>Mohamed</surname><given-names>A</given-names></name><name><surname>Hadam</surname><given-names>J</given-names></name><etal/></person-group><year>2000</year><article-title>Epileptogenicity correlated with increased N-methyl-D-aspartate receptor subunit NR2A/B in human focal cortical dysplasia.</article-title><source>Epilepsia</source><volume>41</volume><fpage>971</fpage><lpage>976</lpage><pub-id pub-id-type="pmid">10961623</pub-id></citation></ref><ref id="pone.0005808-Ying1"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>Z</given-names></name><name><surname>Bingaman</surname><given-names>W</given-names></name><name><surname>Najm</surname><given-names>IM</given-names></name></person-group><year>2004</year><article-title>Increased numbers of coassembled PSD-95 to NMDA-receptor subunits NR2B and NR1 in human epileptic cortical dysplasia.</article-title><source>Epilepsia</source><volume>45</volume><fpage>314</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">15030493</pub-id></citation></ref><ref id="pone.0005808-Sisodiya1"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sisodiya</surname><given-names>SM</given-names></name><name><surname>Thom</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>WR</given-names></name><name><surname>Bajaj</surname><given-names>NP</given-names></name><name><surname>Cross</surname><given-names>JH</given-names></name><etal/></person-group><year>2002</year><article-title>Abnormal expression of cdk5 in focal cortical dysplasia in humans.</article-title><source>Neurosci Lett</source><volume>328</volume><fpage>217</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">12147310</pub-id></citation></ref><ref id="pone.0005808-Sen2"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>A</given-names></name><name><surname>Thom</surname><given-names>M</given-names></name><name><surname>Martinian</surname><given-names>L</given-names></name><name><surname>Yogarajah</surname><given-names>M</given-names></name><name><surname>Nikolic</surname><given-names>M</given-names></name><etal/></person-group><year>2007</year><article-title>Increased immunoreactivity of cdk5 activators in hippocampal sclerosis.</article-title><source>Neuroreport</source><volume>18</volume><fpage>511</fpage><lpage>516</lpage><pub-id pub-id-type="pmid">17496813</pub-id></citation></ref><ref id="pone.0005808-Chae1"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chae</surname><given-names>T</given-names></name><name><surname>Kwon</surname><given-names>YT</given-names></name><name><surname>Bronson</surname><given-names>R</given-names></name><name><surname>Dikkes</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>E</given-names></name><etal/></person-group><year>1997</year><article-title>Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality.</article-title><source>Neuron</source><volume>18</volume><fpage>29</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">9010203</pub-id></citation></ref><ref id="pone.0005808-Patel1"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>LS</given-names></name><name><surname>Wenzel</surname><given-names>HJ</given-names></name><name><surname>Schwartzkroin</surname><given-names>PA</given-names></name></person-group><year>2004</year><article-title>Physiological and morphological characterization of dentate granule cells in the p35 knock-out mouse hippocampus: evidence for an epileptic circuit.</article-title><source>J Neurosci</source><volume>24</volume><fpage>9005</fpage><lpage>9014</lpage><pub-id pub-id-type="pmid">15483119</pub-id></citation></ref><ref id="pone.0005808-Wenzel1"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname><given-names>HJ</given-names></name><name><surname>Robbins</surname><given-names>CA</given-names></name><name><surname>Tsai</surname><given-names>LH</given-names></name><name><surname>Schwartzkroin</surname><given-names>PA</given-names></name></person-group><year>2001</year><article-title>Abnormal morphological and functional organization of the hippocampus in a p35 mutant model of cortical dysplasia associated with spontaneous seizures.</article-title><source>J Neurosci</source><volume>21</volume><fpage>983</fpage><lpage>998</lpage><pub-id pub-id-type="pmid">11157084</pub-id></citation></ref><ref id="pone.0005808-Lee1"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Kwon</surname><given-names>YT</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Friedlander</surname><given-names>RM</given-names></name><etal/></person-group><year>2000</year><article-title>Neurotoxicity induces cleavage of p35 to p25 by calpain.</article-title><source>Nature</source><volume>405</volume><fpage>360</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">10830966</pub-id></citation></ref><ref id="pone.0005808-Ketelaars1"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ketelaars</surname><given-names>SO</given-names></name><name><surname>Gorter</surname><given-names>JA</given-names></name><name><surname>van Vliet</surname><given-names>EA</given-names></name><name><surname>Lopes da Silva</surname><given-names>FH</given-names></name><name><surname>Wadman</surname><given-names>WJ</given-names></name></person-group><year>2001</year><article-title>Sodium currents in isolated rat CA1 pyramidal and dentate granule neurones in the post-status epilepticus model of epilepsy.</article-title><source>Neuroscience</source><volume>105</volume><fpage>109</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">11483305</pub-id></citation></ref><ref id="pone.0005808-Arroyo1"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arroyo</surname><given-names>S</given-names></name><name><surname>Brodie</surname><given-names>MJ</given-names></name><name><surname>Avanzini</surname><given-names>G</given-names></name><name><surname>Baumgartner</surname><given-names>C</given-names></name><name><surname>Chiron</surname><given-names>C</given-names></name><etal/></person-group><year>2002</year><article-title>Is refractory epilepsy preventable?</article-title><source>Epilepsia</source><volume>43</volume><fpage>437</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">11952776</pub-id></citation></ref><ref id="pone.0005808-Cooper1"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>DC</given-names></name><name><surname>Chung</surname><given-names>S</given-names></name><name><surname>Spruston</surname><given-names>N</given-names></name></person-group><year>2005</year><article-title>Output-mode transitions are controlled by prolonged inactivation of sodium channels in pyramidal neurons of subiculum.</article-title><source>PLoS Biol</source><volume>3</volume><fpage>e175</fpage><pub-id pub-id-type="pmid">15857153</pub-id></citation></ref><ref id="pone.0005808-Fowler1"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fowler</surname><given-names>MA</given-names></name><name><surname>Sidiropoulou</surname><given-names>K</given-names></name><name><surname>Ozkan</surname><given-names>ED</given-names></name><name><surname>Phillips</surname><given-names>CW</given-names></name><name><surname>Cooper</surname><given-names>DC</given-names></name></person-group><year>2007</year><article-title>Corticolimbic Expression of TRPC4 and TRPC5 Channels in the Rodent Brain.</article-title><source>PLoS ONE</source><volume>2</volume><fpage>e573</fpage><pub-id pub-id-type="pmid">17593972</pub-id></citation></ref><ref id="pone.0005808-Lauterborn1"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lauterborn</surname><given-names>JC</given-names></name><name><surname>Rex</surname><given-names>CS</given-names></name><name><surname>Kramar</surname><given-names>E</given-names></name><name><surname>Chen</surname><given-names>LY</given-names></name><name><surname>Pandyarajan</surname><given-names>V</given-names></name><etal/></person-group><year>2007</year><article-title>Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome.</article-title><source>J Neurosci</source><volume>27</volume><fpage>10685</fpage><lpage>10694</lpage><pub-id pub-id-type="pmid">17913902</pub-id></citation></ref><ref id="pone.0005808-Chemelli1"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chemelli</surname><given-names>RM</given-names></name><name><surname>Willie</surname><given-names>JT</given-names></name><name><surname>Sinton</surname><given-names>CM</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name><name><surname>Scammell</surname><given-names>T</given-names></name><etal/></person-group><year>1999</year><article-title>Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.</article-title><source>Cell</source><volume>98</volume><fpage>437</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">10481909</pub-id></citation></ref><ref id="pone.0005808-Racine1"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Racine</surname><given-names>RJ</given-names></name></person-group><year>1972</year><article-title>Modification of seizure activity by electrical stimulation. I. After-discharge threshold.</article-title><source>Electroencephalogr Clin Neurophysiol</source><volume>32</volume><fpage>269</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">4110396</pub-id></citation></ref><ref id="pone.0005808-Shah1"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>MM</given-names></name><name><surname>Anderson</surname><given-names>AE</given-names></name><name><surname>Leung</surname><given-names>V</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Johnston</surname><given-names>D</given-names></name></person-group><year>2004</year><article-title>Seizure-induced plasticity of h channels in entorhinal cortical layer III pyramidal neurons.</article-title><source>Neuron</source><volume>44</volume><fpage>495</fpage><lpage>508</lpage><pub-id pub-id-type="pmid">15504329</pub-id></citation></ref><ref id="pone.0005808-Geyer1"><label>67</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Geyer</surname><given-names>MA</given-names></name><name><surname>Dulawa</surname><given-names>SC</given-names></name></person-group><year>2003</year><person-group person-group-type="editor"><name><surname>Jacqueline Crawley</surname><given-names>CG</given-names></name><name><surname>Rogawski</surname><given-names>Michael</given-names></name><name><surname>Sibley</surname><given-names>David</given-names></name><name><surname>Skolnick</surname><given-names>Phil</given-names></name><name><surname>Wray</surname><given-names>Susan</given-names></name><name><surname>McKay</surname><given-names>Ron</given-names></name><name><surname>Taylor</surname><given-names>Gwen</given-names></name></person-group><source>Current Protocols in Neuroscience</source><publisher-name>John Wiley &#x00026; Sons, Inc</publisher-name></citation></ref><ref id="pone.0005808-Blundell1"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blundell</surname><given-names>J</given-names></name><name><surname>Tabuchi</surname><given-names>K</given-names></name><name><surname>Bolliger</surname><given-names>MF</given-names></name><name><surname>Blaiss</surname><given-names>CA</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><etal/></person-group><year>2009</year><article-title>Increased anxiety-like behavior in mice lacking the inhibitory synapse cell adhesion molecule neuroligin 2.</article-title><source>Genes Brain Behav</source><volume>8</volume><fpage>114</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">19016888</pub-id></citation></ref><ref id="pone.0005808-Kwon1"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>CH</given-names></name><name><surname>Luikart</surname><given-names>BW</given-names></name><name><surname>Powell</surname><given-names>CM</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Matheny</surname><given-names>SA</given-names></name><etal/></person-group><year>2006</year><article-title>Pten regulates neuronal arborization and social interaction in mice.</article-title><source>Neuron</source><volume>50</volume><fpage>377</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">16675393</pub-id></citation></ref><ref id="pone.0005808-Gold1"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>SJ</given-names></name><name><surname>Heifets</surname><given-names>BD</given-names></name><name><surname>Pudiak</surname><given-names>CM</given-names></name><name><surname>Potts</surname><given-names>BW</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><year>2002</year><article-title>Regulation of regulators of G protein signaling mRNA expression in rat brain by acute and chronic electroconvulsive seizures.</article-title><source>J Neurochem</source><volume>82</volume><fpage>828</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">12358788</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was made possible by a NIDA training grant (A.H.H.), NIDA K-award (D.C.C.), NARSAD Young Investigator award (D.C.C. and K.H.), Hartwell Foundation Biomedical Research Fellowship (C.M.P), Lowe Foundation, VanBeber Family and Crowley Family (C.M.P.) and R01 grant from the National Institutes on Mental Health (J.A.B. and C.M.P.) and Drug Abuse (J.A.B. and D.C.C.). Portions of this research was made possible by the Gulf War Illness Research Program (Contract No. VA549-P-0027, Year 1 Task Order Obligation No. 549-D95018) from the US Department of Veterans Affairs/Veterans Affairs IDIQ contract (awarded administered by the Dallas, TX, VA Medical Center; C.M.P., J.A.B. and D.C.C.), for which we are obligated to state that the content of the information does not necessarily reflect the position or the policy of the Federal government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article> 